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 Drosophila Robo2 axon guidance receptor is a member of the evolutionarily conserved 
Roundabout (Robo) protein family that is involved in directing axons that cross the midline to 
the other side of the animal body. Robo2 roles mainly depend on two factors: The functional 
domains of the Robo2 protein, which is extensively studied, and the dynamic transcription of 
robo2 in various subsets of cells throughout embryogenesis which is not fully understood. Thus, 
knowing robo2 enhancers that transcriptionally regulate robo2 during embryogenesis is 
significant. To investigate robo2 potential enhancers, we screened 17 transgenic lines of 
Drosophila that were generated by Janelia Research Center. These lines contain 17 fragments 
distributed within and around the robo2 gene. We identified six fragments that regulated robo2 
expression by the GAL4-UAS-GFP system suggesting that they were promising enhancers. 
Using these identified regulatory fragments in addition to three fragments generated in our lab, 
we built the HA-Robo2 transgenic constructs. These constructs were introduced into Drosophila 
which allowed us to test robo2 expression and its dependent axon guidance phenotypes in the 
embryonic CNS. GMR28G05 and GMR28F02 fragments showed the strongest robo2 expression 
in the lateral pathway. To further study these fragments, we introduced them separately or 
together into robo2 null mutant background. We found that Robo2’s dynamic expression pattern 
is specified by multiple regulatory regions. 
 We utilized these fragments to generate and characterize an equivalent set of robo2 
transgenes expressing the axonal marker TauMyc instead of the HA-Robo2 and hsp70 promoter 
instead of robo2 promoter. The results show that GMR28F02 fragment drove strong expression 
of TauMyc in a subset of the lateral neurons, cell bodies, and commissural axon from which 
Robo2 protein is expressed.  
CRISPR/Cas9 system was used to further investigate the importance of our findings. 
Cas9 protein and specific gRNAs were used to target and delete robo2 potential enhancers 
(GMR28G05 and GMR28F02) separately or together. Applying bioinformatics tools and 
literature I predicted three transcription factors (Hb9, Nkx6.1, and Lhx2) that have a high 
probability to bind robo2 potential enhancers.  
In summary, robo2 has potential enhancers located in the first intron and upstream of the 
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Chapter one: Axon Guidance role in the central nervous system (CNS) of Drosophila 














 Animals with bilateral symmetry sense and respond to their environment through their 
nervous system (Comer et al.,  2019). During the nervous system development, the formation of 
a network between neuronal and non-neuronal cells is one of the most interesting processes. The 
key step in this process is the axons that extend precisely towards their desired synaptic targets. 
Researchers have extensively studied this phenomenon a few decades ago using cellular and 
molecular mechanisms controlling the navigation and neuronal growth (Dickson & Zou, 2010; 
Hidalgo & Booth, 2000; Sáchez-Soriano et al.,  2007; Raper & Mason, 2010; Tessier-Lavigne & 
Goodman, 1996). Neuronal circuit development is orchestrated by axon guidance molecules such 
as slit, the repellent ligand of the roundabout receptor (Robo), and netrin-1 which induces 
attraction by frazzled receptor (DCC in vertebrates). Individuals with CNS limitation show 
defects in the proteins engaged in axon guidance decisions. For example, a heterozygous 
mutation in DCC causes congenital mirror movements disorder. Individuals with this kind of 
disorder miss the ability to move both sides of the body independently, and this rare issue 
persists throughout the patient’s life (Galléa et al.,  2011). Also, Robo1 disruption is implicated 
in communication disorder with dyslexia, a disorder characterized by trouble with reading, 
spelling, and pronouncing words, and writing. This disruption is caused by chromosome 
translocation in dyslexic individuals (Hannula-Jouppi et al.,  2005). Moreover, Robo2/Slit2  
disorder has been involved in the vesicoureteral reflux (VUR), a complex, genetically 
heterogeneous developmental disorder described by the retrograding flow of urine from the 
bladder into the ureter (Lu et al., 2007). Furthermore, a homozygous mutation in the human 
robo3 gene located on chromosome 11 causes horizontal gaze palsy with progressive scoliosis 
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(HGPPS) (Amoiridis et al., 2006). This mutation causes the hindbrain axons to fail to cross the 
midline. Individuals with Horizontal gaze palsy develop scoliosis within the first ten years of 
their life. (Nugent et al., 2012) 
 The human brain consists of around 100 billion neurons with 10,000 different cell types 
that have different functions such as sensory neurons, motor cells, and memory cells, making 
humans the most complex organism (Herculano-Houzel, 2009; Muotri & Gage, 2006). Despite 
being different anatomically, smaller organisms such as Drosophila still share several conserved 
cellular and genetic properties with humans (Venken et al., 2011). Being less complex than 
humans, Drosophila was utilized as one of the most powerful model organisms in biomedical 
science for more than a decade. The cheap, short generation time, a huge amount of progeny, and 
very advanced genetic tools have made Drosophila requisite for biological research (Tolwinski, 
2017). All these qualities in Drosophila encouraged the researchers to use it as a model to obtain  
novel insight into the tools and mechanisms that can assist to suggest new treatments for various 
neurological diseases (Ugur et al.,  2016). 
Development of the CNS in Drosophila 
The early development of Drosophila CNS involves the differentiation of neuroblasts. 
Neuroblasts are produced first by splitting from a neuro-ectoderm that is housed in the 
ventrolateral section of the Drosophila embryo. They start dividing to form neurons and glia. 
These neuroblasts keep dividing to generate another neuroblast and ganglion mother cell (GMC). 
The latter (GMC) divides only one time to give rise to neurons and glial cells, the two essential 
cell types build up the CNS (McDonald et al.,  1998; Homem & Knoblich, 2012). While neurons 
have two processes: axons and dendrites synapsis, glial cells have only one process and no 
synapsis. In Drosophila melanogaster, the CNS contains two types of glial cells, midline glia 
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(MG) cells, and the lateral glia. MG cells are a subclass of neuropile glia that are expressed in the 
early stage of embryogenesis and reduced during the pupal stage just before turning to adult fly 
(Awad & Truman, 1997). They play a crucial role in embryonic signaling and wrapping the 
axons that cross the CNS. Once connect to the adjacent neurons, MG cells get access to perform 
multiple tasks, such as migration, ensheathment, subdivision of axon commissures, apoptosis, 
and extension of glial processes. MG cells in Drosophila are functionally and morphologically 
akin to mammalian floorplate cells (Crews, 2010) making the midline an essential point to 
orchestrate axon pathfinding (Crews, 2010; Kaprielian et al.,  2001). 
Axon guidance  
Information is transferred between the two halves of the nervous system through 
commissures, which consist of neurons that extend axons across the midline to the other side of 
the CNS. While some axons cross the midline once, others such as ipsilateral axons never cross 
the midline. Instead, they extend exclusively on their own side of the CNS (Rajagopalan, Nicolas 
et al.,  2000). At the beginning of the differentiation, neurons eject multiple projections called 
neurites. However, only one of these neurites develops an axon. Neurons send out their axons to 
reach their destination to make synaptic connections with other neuronal and non-neuronal cells. 
These axons can extend over very short or very long distances. So, for the axons to reach their 
long-distance targets, they should grow to attain this goal. The previous studies proposed two 
approaches for the axons to grow. The first approach suggests that axon pathways are broken 
into shorter intervals or segments of about a hundred micrometers long. These segments act as 
intermediate targets that the axons regulate the navigation by providing information that guides 
the axons to grow along the next segment of the trajectory (Kaprielian et al.,  2001). The second 
approach for the axon extension to a long-distance proposes that pioneer axons that project early 
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in the developing neurons pave the way for the later-developing axons to track the same way that 
the early axons established to reach their final destination (Tessier-Lavigne & Goodman, 1996). 
Now that these approaches simplified the task of axons navigation through a long-distance by 
having the long axons divided into short intervals, the question remains as to how these short 
intervals of axons are formed? Genetic tools, tissue culture studies, and embryological 
experiments show that there are four types of cues or molecules that axons respond to: short-
range attractants, short-range repellents, long-range attractants (chemoattractants), and long-
range repellents (chemorepellents). Roman Y. Cajal was the first one who discovered the 
growing tips of the axons about one hundred years ago. He anticipated that chemoattractant 
might mediate axon guidance decision when he proposed that target cells release chemoattractant 
substances to attract axons over a distance in a process similar to the chemotaxis in attracting 
motile cells to their targets in a response to a diffusible chemoattractant substance from the target 














Figure 1.1. Four types of guidance forces associated with guiding growth cones: 
contact attraction, chemoattraction, contact repulsion, and chemorepulsion. (Top left 
and right), netrin ligand that is involved in both chemoattraction and chemorepulsion 
mechanisms. (Bottom, right), contact repulsion represented by Ephrin ligands, 
transmembrane semaphorins and extracellular membrane (ECM). (Bottom, left), 
adhesion molecules represented by immunoglobulins, cadherins, and ECMs. Adapted 




Axon guidance molecules 
Axons traverse through their environment in which different signaling molecules are 
displayed on or secreted into the interstitial space of extracellular matrix by neuronal and non-
neuronal cells. These molecules are represented by adhesive molecules, trophic molecules, 
modulatory factors, tropic factors, and differentiation and morphogenic factors (Raper & Mason, 
2010) (Figure 1.2). 
A. Adhesive factors 
For the axons to be protruded in their environment, they need suitable substrates called 
adhesive factors. There are two major types of adhesive cues: extracellular matrix (ECM) 
constituents, which are expressed on basement membrane or cellular interstices, and cell 
adhesion molecules (CAMs) expressed on neuronal and non-neuronal surfaces. Adhesive cells 
assist physical contact with the substrate required for axon extension. Laminin and fibronectin 
are two examples of adhesion molecules in the ECM, and cadherins and immunoglobulin family 
are two other examples of adhesion molecules on the cell surfaces (Raper & Mason, 2010). 
B. Trophic signals 
These signal molecules enhance axon outgrowth, the motility of growth cones, and 
neuronal survival (Reichardt, 2006); Connolly et al.,  1985). In vitro axonal outgrowth can be 
affected by the neurotrophins concentration. When they get closer to their targets, neurotrophins 





C. Modulatory cues 
These are signaling molecules that are not attractants or repellants on their own. 
However, they act by modulating the effectiveness of other guidance cues (Raper & Mason, 
2010). For instance, even though these cues are not tropic, they can affect the way the axons 
respond to the tropic cues. Chemokines, such as stromal cell-derived factor 1(SDF1) and 
Laminin are examples of these types of cues. So, SDF1, or neurotrophins, for example, can  
reduce the axon response to the repellent Semaphorin 3A  even though they are not 
Semaphorines on their own (Dontchev & Letourneau, 2002). 
D. Tropic cues 
This category of cues involves the chemotactic cues hypothesized by Roman Y. Cajal. 
The major roles of these cues are attraction and repulsion. These cues are responsible for creating 
remarkable changes in growth cone motility by influencing the cytoskeleton through intracellular 
signaling. Examples of these cues are netrins, semaphorins, ephrins, and slits (Luo et al.,  1993; 
Renzi et al.,  2000) 
D.1. Netrins: They are secreted proteins that can act as both repellent and attractant in axon 
guidance in the midline depending on their binding to particular receptors, such as unc-40 and 
unc-5 that encode the conserved transmembrane proteins (Culotti & Merz, 1998). During 
neurogenesis, netrins can act as either long- or short-range signals. 
D.2. Semaphorins: Unlike netrins, semaphorins such as semaphorin 3A, is a secreted repellent 
that prevents the growing of axons from inappropriate regions. In addition to being axon 
guidance repellents, semaphorins act as short-range inhibitory signals. Due to their existence in 
the scar tissue, class 3 semaphorins play a crucial role in central nervous system injuries such as 
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axonal regrowth, re-vascularisation, re-myelination, and the immune response (Mecollari et al.,  
2014). 
D.3. Ephrins: They are a family of membrane-bound proteins that act as ligands of Eph 
receptors. Signaling of Eph/ephrin leads to the regulation of multiple biological events during 
embryonic development, such as cell migration, the building of tissue boundaries, segmentation, 
and axon guidance of growth cones. During adulthood, ephrins play a role in some processes like 
angiogenesis and stem cell differentiation. Based on their structure and binding to the cell 
membrane, ephrin ligands fall into two subclasses: ephrin-A and ephrin B. Eph receptors, in turn, 
are divided into two types ephAs and ephBs depending on their affinity to bind ephrin-A or 
ephrin B ligands (Nomenclature & Ligands, 1997). 
D.4. Slit: It is a secreted extracellular matrix protein that plays an active role in neuronal 
development. The major function of Slit protein is acting as midline repellent by deflecting the 
longitudinal axons from crossing the midline of CNS. It also participates in preventing 
commissural axons from re-crossing the midline. The canonical receptor for Slit is Robo 
transmembrane proteins. In vertebrates, slit is produced by the cells in the floor plates, while in 
insects, including Drosophila, slit protein is produced by midline glia. Pioneer axon guidance 
depends mainly on Slit/Robo signaling (Farmer et al.,  2008). 
E. Morphogenic and differentiation factors 
      These are signaling molecules that stimulate the cells to produce specific responses according 
to their local concentration. During the early development, morphogens are produced as 
gradients by specific cells and release through the tissue around these cells. These gradients are 
responsible for driving the differentiation of stem cells into different cell types. Eventually, 
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forming all the body tissues and organs. The majority of morphogens are secreted proteins that 
act as signaling molecules between the cells. However, some of them diffuse in the 



















Figure 1.2. Axon guidance impacted by environmental cues: Different signaling 
molecules are released or displayed on the surface of the neuronal and non-neuronal 
cells where axons moving through. These molecules include morphogenic and 
differentiation factors that play important role in neurons determination, trophic, 
adhesive, modulatory, and tropic factors that affect the growth cones based on the 
guidance receptors and signaling components found in the growth cone. Growth 
cones motility is affected by signaling pathway resulted from specific guidance cues 
and according to these signaling pathways growth cones, eventually respond 
differently by pausing, collapsing, withdrawing, turning, or fasciculation with 






During the nervous system development, the neuronal network establishment requires 
extending the axons toward their suitable postsynaptic target cells. The process of extending 
neurons to their axons occurs at the growth cones of the axons distal tips (Dent et al.,  1999; Dent 
& Gertler, 2003; Lowery & Vactor, 2009; Sánchez-Soriano et al.,  2010). Growth cones are large 
extensions developing or regenerating neurites looking for their appropriate synaptic targets 
supported by actin (Vitriol & Zheng, 2012). The morphology of growth cones looks like a 
human hand, it consists of two types of cytoskeletal elements which, in turn, lies in two regions, 
the organelle-rich central domain, which consists of microtubules, and the organelle-poor 
peripheral domain where actin filaments predominate and form two types of extensions: 
filopodia and lamellipodia. Filopodia are fine and pointed extensions, they are also called 
microspikes. They consist of bundles of actin filaments (F-actin) that provide the growth cones 
with support and shape. Filopodia are bound by a membrane rich with receptors and cell 
adhesion molecules which are necessary for axon growth and guidance. Unlike filopodia, 
lamellipodia are flat regions of actin meshwork. lamellipodia are located between two filopodia. 
Due to their quite dynamic merits, growth cones can respond to the surrounding environmental 
stimuli by branching towards the stimuli and switching their directions (Dent & Gertler, 














Figure 1.3. Neuronal growth cone. Growth cone is the motile human hand-like structure 
that navigate through the environment in response to specific cues. It consists of two 
cytoskeletal elements, which are distributed in two regions, the C region represents 
organelle-rich central domain, which involves microtubules that extend to the base of 
the filopodia, and P region that represents the organelle-poor peripheral domain where 
actin filaments predominate forming filopodia and lamellipodia. This figure is adapted 




 Robo family  
Drosophila genome screen for mutant genes that play a key role in axon guidance 
revealed the discovery of a special group of proteins called a roundabout. Roundabout or Robo is 
a family of transmembrane protein receptors that are highly conserved among many animal taxa. 
This family obtained its name (roundabout) from the circular-like traffic junctions, a phenotype 
that resulted from axon crossing and improperly re-crossing the midline in Drosophila robo 
mutant (Evans & Bashaw, 2012; Kidd et al.,  1998). Robo receptors play a pivotal role in 
nervous system development. Phylogenetic analysis shows that Robo receptors have developed 
from certain ancestral proteins with multiple variations occurred over time in various lineages. 
The robo gene was first discovered in Drosophila and has been cloned in different species such 
as humans and mice. In invertebrates, such as Drosophila, the Robo family consists of three 
Robo receptor members: Robo1, Robo2, and Robo3. (Rajagopalan, Vivancos et al.,  2000; 
Simpson, Kidd et al.,  2000). Whereas in vertebrates, such as humans, the Robo family consists 
of four Robo receptors: Robo1, Robo2, Robo3/Rig-1, and Robo4/magic roundabout. In 
Drosophila, robo1 is located on chromosome 2R while robo2 and robo3 are located on the left 
arm of the second chromosome (2L). In humans, robo1 and robo2 are located on chromosome 
3p123, while robo3 and robo4 are placed on chromosome 11 p24.2.  
 Robo protein structure 
Drosophila Robo family three members (Robo1, Robo2, and Robo3) share a 5+3 
conserved ectodomain protein structure of five immunoglobulin-like (Ig) domains and three 
fibronectin type III-like domains (FN). The cytoplasmic portion in Robo2 and Robo3 is shorter 
and consists of only two cytodomains (CC0, and CC1), while Robo1 consists of four 
cytodomains (CC0, CC1, CC2, and CC3). The cytoplasmic motifs of the Robo family are 
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required for interactions with downstream effectors. (Kidd et al.,  1998; Bashaw et al.,  2000) 
(Figure 1.4). 
Robo2 
Robo2 is a transmembrane protein that belongs to an evolutionarily conserved protein 
family called a roundabout. This family plays an active role in axon guidance. As a 
transmembrane protein, Robo2 structure includes mainly extracellular portion consists of five 
immunoglobulin-like domains and three fibronectin-like repeats, transmembrane, and a 
cytoplasmic domain made up of two cytoplasmic conserved motifs (CC0 and CC1). During the 
early stages of axon trajectory, Robo2 is expressed in the ipsilateral pioneer axon where it 
mediates midline repulsion. Robo2 also inhibits slit Robo1 repulsion by being expressed in the 
midline cells. So, Robo2 promotes midline crossing (Evans et al.,  2015). Furthermore, Robo2 is 
expressed in the lateral regions of the neuropile in the late stages of nerve cord development to 
enhance the formation of longitudinal axon pathways. The distinct roles of Robo2 depend in part 
on different functional domains within its receptor protein, and on its dynamic expression in 
different subsets of cells during embryogenesis in another part. Robo2 Ig1 domain is the 
canonical Slit ligand-binding domain, which is essential for midline repulsion. Ig1 and Ig3 
domains of Robo2 affect Robo2’s ability to control the lateral positions of longitudinal axons 
while the Ig2 domain is required for promoting midline crossing (Evans & Bashaw, 2010b). 
RNA seq data show that Drosophila Robo2 is expressed at a high-level in CNS and imaginal 
disc. In Drosophila, robo2 expression levels are more likely organ-dependents. Studies showed 
that robo2 has moderate expression in the fat body while it has a low expression in the head, 
salivary gland, digestive system, testis, and accessory gland. Like robo2 expression in 
Drosophila, robo2 expression in humans is organ dependent. It has been found that Robo2 was 
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expressed in a high level in the fetal brain, endocrine tissues, lung, kidney, urinary bladder, and 
lower in bone marrow, salivary gland, thyroid gland, skin, adipose and soft tissues, pancreas, 
























Figure 1.4.A schematic shows three robo family members (Robo1, Robo2, 
and Robo3) each of which consists of the 5+3 conserved ectodomain, 
transmembrane domain, and cytodomains, which are two in both of Robo2 
and Robo3(CC0, and CC1)), and four motifs in Robo1(CC0, CC1, CC2, and 
CC3). Slit binds to the first immunoglobulin-like domain (Ig1) of the robo 
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The expression patterns and mutant phenotypes of the Drosophila Robo family 
All Robo proteins are expressed in the embryonic CNS during the period of axon 
outgrowth. Kidd et al., 1998a shows that Robo1 is expressed in the CNS during the formation of 
the pathways in a consistent pattern. While Robo2 is expressed transiently during the 
embryogenesis stages, Robo2 is extensively expressed during stage 12. However, its expression 
becomes more restricted at later stages to a specific cell subset. Robo3, in turn, is the last Robo 
family to be expressed in the CNS. It starts its expression at stage 13 of embryogenesis and this 
expression is restricted to a subset of cells since the beginning of its expression. Compared to 
robo2, robo3 shows more expression than robo2 in the later stages of embryogenesis. While 
robo1 and robo2 show a high degree of similarity in their expression patterns in the periphery, 
robo3 shows different peripheral expressions. robo3 is exclusively expressed in PNS neurons, 
while robo2 is expressed in the epidermis as stripes in addition to the developing trachea, dorsal 
vessel, and muscles.  
All Robos are highly expressed in the longitudinal growth cones. However, their 
expression is very low in the commissural growth cones. By the end of the developmental 
embryogenesis, each one of the three Robos emerges in a particular pattern. For example, Robo1 
is expressed in the entire width of the longitudinal tracts, robo2 shows expression on axons in the 
lateral two-thirds, and Robo2 is expressed on axons in the lateral one-third of the longitudinal 
tracts (Figure 1.5). According to their expression patterns, the three Robos divide the 
longitudinal tracts into three zones: a medial zone, which consists of only robo1 expression, an 
intermediate zone composed of both robo1 and robo3, and a lateral zone, which consists of all 
the three Robos (Rajagopalan, Vivancos et al.,  2000). 
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Robo1 plays a major role in regulating axon guidance in the midline. In robo1 mutant, axons 
cross the midline repeatedly without staying at the midline each time they cross it (Simpson, 
Kidd et al.,  2000) (Figure 1.6, B). In robo2 mutants, the lateral longitudinal pathway merges into 
the intermediate pathway in addition to the defect this mutation causes in the midline crossing 
represented by crossing some axons the midline at a level lower than the one that has seen in 
robo1 mutant (Figure 1.6, C). In robo3 mutants, the intermediate longitudinal pathway shows 
shifting medially to be fused with the medial pathway. However, the mutant phenotype does not 












Figure 1. 5. Robo1, Robo2, and Robo3 partition the longitudinal tract into three zones. 
Stage 12 to early stage 13 of Drosophila CNS of wild type embryos. robo1 and robo2 
share the same pattern of expression at stage early 13 with high level of protein expression 
in the longitudinal pathway (arrow) and no protein detectable on axons of the growth 
cones of commissure (arrowhead). The second panel shows Robo3 in older embryos than 
Robo1 and Robo2 panels. The expression of robo3 is very low at this stage. At later 
stages of embryogenesis robo2 becomes more restricted to be expressed in fewer axons 
but its expression pattern is still close to Robo1. Robo3 is more detectable in stage 14. 
Stage 16   shows the three robos expression in the longitudinal pathways in three distinct 


















robo2 robo3 1 
Figure 1.6. robo mutants. A. Wild type Drosophila embryo at stage 16 stained by anti-
FasII antibody 1D4 shows FasII three longitudinal pathways on each side of the midline. 
B. robo1 mutant shows ectopic crossing and re-crossing the midline by medial FasII 
pathway. However, the intermediate and lateral pathways are not affected by this mutation 
and they are more resemble to the wild type. C. robo2 mutant. The lateral pathway (the 
third fascicle) fused with the second pathway (the intermediate) (arrows) and arrowhead 
shows the midline crossing. D. robo3 mutant embryo shows shifting of the second 
pathway (arrowheads) to be merged with the medial pathway (arrows) and there is no 
midline crossing. (A and B images adapted from (Simpson, Kidd et al., 2000), and C and 











Chapter Two: Transcriptional regulation of the robo2 gene in the Drosophila 













Robo2 is a transmembrane protein that regulates three distinct roles in directing axon 
guidance in Drosophila central nervous system (CNS). These various roles of Robo2 depend in 
part on its distinct functional domains and on the dynamic transcription in different subsets of 
cells through embryogenesis in another part. The Robo2 structural and functional domains in 
Drosophila were studied extensively in the previous years. However, little is known about the 
transcriptional regulation of robo2. This chapter focuses on testing multiple regulatory regions 
around the robo2 gene that represent potential enhancers for robo2. We utilized 17 transgenic 
lines generated by Janelia GAL4 research campus in addition to three transgenic lines generated 
in our lab where each transgenic line possesses one of the potential enhancers (fragments) of 
robo2. Two of these fragments (GMR28GO5 and GMR28FO2) drove strong expression of 
robo2 in subsets of the lateral pathway of the Drosophila’s Ventral Nerve Cord (VNC), while the 
other two fragments (GMR28B05 and GMR28E07) enhanced robo2 expression in the midline 
glia. Noticeably, individual fragments were not sufficient to fully rescue robo2 expression in 
robo2 null mutant background. Although one of these fragments (GMR28G05) rescued the 
midline repulsion of the robo2 in a mutant background, its expression was not enough to rescue 
the lateral pathway defect. In this study, we found that a combination of two fragments is enough 







The nervous system of vertebrates and non-vertebrates is essential for processing 
information and sensing the environment through the basic five senses. Any developmental 
defects in the central nervous system (CNS), including proteins involved in axon guidance, can 
cause neurological dysfunction such as neurodegeneration, epilepsy, stroke, dementia, traumatic 
brain injury, and brain tumors. Despite anatomical differences in the CNS of vertebrates like 
humans and invertebrates like Drosophila, they still share several conserved cellular and genetic 
properties. For instance, there are around113 different types of neurons have been found in 
Drosophila visual system, and a very similar number of these neurons have been identified in 
vertebrates (Fischbach & Dittrich, 1989; Dacey & Packer, 2003; Venken et al.,  2011). However, 
there is a huge number of neurons can be found in vertebrates that are missing in flies. This 
reduction in complexity and the feasibility of studying the nervous system in Drosophila helped 
the researchers to use Drosophila as a model to obtain novel insight into the tools and 
mechanisms that can assist to suggest new treatments for various neurological diseases (Ugur et 
al.,  2016). 
During development, the nervous system relies on axon guidance cues to decide whether 
axon fibers cross the midline to the other side of the nervous system or stay on the same side of 
the body. These cues can act as attractants or repellents, and axonal growth cones play an 
important role in directing these axons to their targets. In Drosophila, a transmembrane protein 
family can act as receptors to the repellants. Drosophila has three transmembrane proteins called 
roundabout (Robo) proteins (Robo1, Robo2, and Robo3), all of which are responsible for axonal 
midline repulsion. However, one of these proteins, Robo2, has three distinct roles. In addition to 
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axonal repulsion, Robo2 can mediate pro-crossing the midline and promotes the formation of the 
longitudinal pathway (Rajagopalan, Vivancos et al.,  2000; Simpson, Bland et al.,  2000) 
Robo2 is a member of an evolutionarily conserved transmembrane protein family called 
roundabout that acts as axon guidance receptors. Robo2 protein consists of two main portions. 
The extracellular portion consists of five immunoglobulin-like (Ig) domains and three 
fibronectin-like (Fn) domains, while the cytoplasmic portion consists of two short, conserved 
motifs (CC0 and CC1) (Figure 2.1). During the early stages of axon trajectory, Robo2 is 
expressed in the ipsilateral pioneer axon where it mediates midline repulsion. Robo2 also inhibits 
slit Robo1 repulsion by being expressed in the midline cells. Furthermore, Robo2 is expressed in 
the lateral regions of the neuropile in the late stages of nerve cord development to enhance the 
formation of the longitudinal axon pathways. Robo2 has been studied in the previous years; 
however, it is not fully understood how Robo2 can regulate diverse axon guidance outcomes. 
The distinct roles of Robo2 depend in part on different functional domains within its receptor 
protein, and on its dynamic expression in different subsets of the cells during embryogenesis in 
another part.  
As our understanding increases about the role of enhancer elements in gene expression, 
the notion of gene regulation becomes more sophisticated. Even though these regulatory 
elements were described previously, the mechanisms by which these regulatory elements work 
still controversial. Genetic variation leads to phenotypic variants and potential diseases. These 
variations are located outside of the genes and more likely in the cis-regulatory elements. 
Therefore, understanding these mechanisms is significant in this field (Pennacchio et al.,  2013).  
     Transcriptional enhancers are short cis-acting DNA sequences that control gene expression 
(Benabdallah & Bickmore, 2016). The human genome contains approximately hundreds of 
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thousands of enhancers. Enhancers can function in a position and orientation-independent 
manner from their target promoters. Although they regulate genes in cis, enhancers can be in 
different positions. They can be found upstream, downstream, or within the introns of a gene. 
Some enhancers were found very close to their target promotors, such as SV40, which was the 
first discovered enhancer. SV40 enhancer is 72 bp tandem in a sequence that is located ̴100 bp 
upstream of the viral core promoter (Benabdallah & Bickmore, 2016). Studies showed that 
deletion of SV40 enhancer can eliminate gene expression and loss the viral activity (Benoist & 
Chambon, 1981; Gruss et al.,  1981). Other enhancers were found far away from their promoter, 
such as but not limited to β-globin (LCR), which can be found tens of kilobases from its target 
promoter, while Shh limb enhancer (ZRS), developmental enhancer, can be located hundreds or 
1000 kb from its target gene (Figure 2.2). This chapter focuses on transcriptional regulation of 
Drosophila robo2 to address the question of how individual genes can lead to different axon 
guidance outcomes. To examine the location of the regulatory regions of the robo2 gene, I tested 
genetic fragments (potential enhancers) in the first intron and upstream of the robo2 gene that 
could be potentially involved in the regulation of robo2 expression. Drosophila transgenic lines 
called Janelia GAL4 lines were used in this experiment. These lines have been generated by 
Janelia Research Campus to investigate the location of enhancers in many neuronal genes 
including robo2. Seventeen of these lines have been created by cloning fragments of robo2 and 
these fragments are inserted upstream of the yeast transcriptional activator GAL4 (Pfeiffer et al.,  
2008). Each one of the seventeen lines was crossed to another transgenic line containing a GAL4 










Figure 2.1: Structure and function of Robo2 receptor. Left panel, Robo2 schematic 
structure, Robo2 is a transmembrane protein consists of extracellular portion contains five 
Ig-like domains and three fibronectin-like domain, and cytoplasmic portion consists of two 
short, conserved motifs (CC0, and CC1). Right panel, schematic of the nerve cord of 
Drosophila. It shows the three distinct axon guidance decisions controlled by robo2 in 
preventing midline crossing by binding to slit (purple), mediating longitudinal pathway 
formation in the lateral neuropile (green), and antagonizing slit-Robo1 repulsion and 












Figure 2.2. Different distances between enhancers and their promoters. (Top) SV40 early 
promoter as an example of an enhancer that is located a few tens of bp from their target 
promoter. (Middle) β-globin locus control region (LCR) as an example of enhancers that 
are found tens of kilobases from their target gene. (Bottom) Shh limb enhancer (ZRS) as 
an example of developmental enhancers that are located hundreds or 1000 kb from their 















Figure 2.3: Janelia GAL4 lines. A schematic shows crosses between UAS-GFP and 
Janelia GAL4 lines containing robo2 fragments. The expression patterns of the GFP is 
directed by the presence or absence of the enhancers in each robo2 fragment. The robo2 
transcription factors in the CNS bind to the robo2 putative enhancers present in each 
fragment upstream of the GAL4. As GAL4 protein produces, it binds to UAS enhancer 
and promotes GFP expression. The GFP expression reflects the expression governed by 
robo2 transcriptional elements. 
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Material and Methods 
Molecular biology  
Rescue construct synthesis: All Janelia GAL4 fragments were amplified by using specific 
primers (Table 4) and fly genomic preparations using Phusion Flash PCR Master Mix (Thermo 
Scientific), Both PUAST vector and Janelia fragments were cut by AscI restriction enzyme. 
Gibson Assembly synthesis reaction or Gibson assembly Ultra Kit (SGI-DNA, Inc. La Jolla, CA 
92037 USA, Cat no.:GA1200-10) were used to fusing Janelia fragments with the P10-UAST 
vector backbone to form a rescue construct vector, which is transformed into competent E. coli 
cells and recovered through mini preparation (Qiaprep spin miniprep kit (250), Cat. no. 27106). 
All the constructs were confirmed by PCR followed by sequencing to ensure that all the 
fragments were inserted correctly into P10-UAST vector. Rescue constructs including Janelia 
GAL4 fragments and robo2 HA-tagged cDNA were inserted at the attB site located at 28E7 
position on the left arm of chromosome 2. The transgenic lines resulted from this cloning 
carrying rescue constructs were crossed to Sco/CyOwg flies which are utilized as genetic 
balancers. 
Immunohistochemistry  
Drosophila embryos were collected, dechorionated, and fixed as previously described in 
(N. H. Patel, 1994) and stored in methanol at -20°C. Fixed embryos were rehydrated in PBT ( 
1XPBS, and 0.1% triton) and blocked in PBT+ 5% NGS  for 30 minutes at room temperature. 
Primary antibody was added and incubated at 4 °C overnight, then washed and incubated with 
PBT for 30 minutes at room temperature. Secondary antibody was added and incubated for 1 
hour at room temperature and washed 3 times with PBT (1XPBS, and 0.1% triton) and then 
rinsed with PBS 10% and mounted in 70% glycerol/PBS. Drosophila embryos were genotyped 
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by using balancer markers or using epitope-tagged transgenes. Embryos were dissected to get the 
nerve cords of desired genotypes in different stages. Nerve cords were mounted in 70% 
glycerol/PBS. Leica SP5 confocal microscope was used for imaging and Fiji/Image J and 
photoshop software (Schindelin et al.,  2009) were used to process the fluorescent confocal 
stacks. 
Combining GMR28F02 and GMR28G05 fragments and Generation of CRISPR-modified 
alleles recovery 
GMR28F02 and GMR28G05 fragments were amplified from genomic DNA preparation 
using specific primers (Table 4) and amplified fragments were extracted from the gel and 
purified using (QIAquick Gel Extraction Kit (250) Cat. No. 28706). Gibson assembly master mix 
used to assemble these fragments in P10-UAST vector backbone that has HA-tag to form a 
rescue construct plasmid. The assembled vector was transformed into competent E. coli cells and 
recovered through minipreparation (QIAprep Spin Miniprep Kit (250), Cat. No. 27106). The 
construct was confirmed by PCR and sequencing. This rescue construct was inserted at attB site 
located at 28E07 on the left arm of chromosome 2 of wild-type fly. The G0 flies from this 
cloning were crossed to Sco/CyOwg to make balanced stocks. Flies from this combination were 
crossed to robo2 null mutant flies. The G0 flies from this cross were individually crossed as 
adults to Sco/CyOwg. F1 males were then crossed individually to Sco/CyOwg virgin females. 
After 3 days, F1 males were removed from crosses and tested by PCR with primers to confirm 






robo2 fragments as putative enhancers reported by GFP expression 
Embryos resulted from crossing the 17 lines of robo2 Janelia GAL4 lines to the UAS-
GFP lines were stained by anti-GFP antibody to label GFP product translated under the control 
of the robo2 putative enhancers. All the 17 lines were screened by scoring the lines according to 
the expression pattern of the GFP in and outside of the CNS, in the Ventral Nerve Cord (VNC), 
and the expression in multiple cell-types of interest that normally express Robo2: commissural 
axons, midline cells, and longitudinal axons (Figure 2.4). Preliminary results show that six of the 
seventeen lines were identified to drive the GFP expression in different axons of VNC. Two of 
these 6 fragments drove the expression of GFP in the lateral axons of VNC (GMR28F02 and 
GMR28G05). Therefore, GMR28F02 and GMR28G05 were selected as putative enhancers 
driving Robo2’s lateral pathway. Two other fragments drove the GFP expression in the midline 
glial cells (GMR28E07 and GMR28B05). So, they were selected as  putative enhancers driving 
robo2 pro-crossing role and considered fragments that have a potential role in midline repulsion 
(Figure 2.5). Worth mentioned that two other fragments GMR28C04, GMR28D10 were noted to 























































































































































































































































































































































































































Figure 2.5.GFP expression. (Up) GMR28F02 and GMR28G05 lines. 
Embryos were stained with anti-HRP and anti-GFP, GFP is expressed in the 
longitudinal axons (arrows). (Down) GMR28E07 and GMR28B05 lines. 
Embryos were stained with anti-GFP and anti-HRP. GFP is expressed in the 
midline glia (arrows).   
 
 




Generating and characterizing Robo2 rescue transgenes expressing an HA-tagged robo2 
cDNA under the control of candidate enhancer regions 
 From the above initial screening of a collection of non-coding DNA fragments in the first 
intron of robo2 suggested that six fragments (GMR28F02, GMR28G05, GMR28E07, 
GMR28B05 GMR28C04, and GMR28D10) have the potential to serve as enhancers for robo2 
and four fragments (GMR28F02, GMR28G05, GMR28E07, and GMR28B05) among these six 
fragments were stronger putative enhancers. To closely characterize the robo2 expression, all the 
above six fragments were introduced into the HA-Robo2 reporter transgene (Figure 2.6), 
(Appendix 5). The transgenic robo2 expression was examined by using an anti-HA antibody. 
The results suggested that four of these fragments: GMR28F02, GMR28G05, GMR28C04, and 
GMR28D10 drove the robo2 expression in different subsets of the longitudinal pathway in stage 
16-17 of embryogenesis (Figure 2.7). On the other hand, two fragments (GMR28E07 and 
GMR28B05) did not show the robo2 expression in the longitudinal pathway at stages 16-17 













Figure 2.6. A schematic of the robo2 rescue construct showing the HA-Robo2 cDNA and 
the inserting site for Janelia GAL4 fragments (GMR28F02, GMR28G05, GMR28C04, 








Figure 2.7: A-D. (GMR28F02)::robo2, (GMR28G05)::robo2, (GMR28C04)::robo2, and 
(GMR20D10)::robo2 transgenic lines showing robo2 expression in the longitudinal 
pathway in stage 16 embryos stained with anti-HA antibody (green), and anti-HRP 















Figure 2.8.A and B. Embryos stage 13 of (GMR28E07)::robo2 and 
(GMR28B05)::robo2 expression showing midline glial cells stained by anti-HA 
antibody(green) (A and B, arrowheads) and some of the longitudinal axons (A, arrow). 
Anti-HRP antibody (magenta) stained Drosophila nerve cord. Lower images (C and D) 
show stage 16 embryos of (GMR28E07)::robo2 and (GMR28B05)::robo2, no expression 




Characterize additional potential regulatory regions not included in the original Janelia 
GAL4 
 In addition to the DNA fragments holding suggested putative regulatory regions in the 
first intron of the robo2 gene, there are potential enhancers situated upstream of the robo2 DNA 
sequence, these regions are not part of the Janelia GAL4 lines. To cover these promoter-proximal 
regions, three additional DNA fragments (SEG01, SEG02, and SEG03) located ̴ 20 kb upstream 
of the robo2 promoter were cloned by introducing them separately into HA–Robo2 reporter 
transgene(Figure 2.9) (Appendix 5). The expression of these transgenes was characterized as 
described in figures 2.10 and 2.11. SEG01 does not show any robo2 expression in the lateral 
pathway at stage16. However, it shows a slight expression at midline glia at stage 13 of 
embryogenesis. SEG02 and SEG03 on the other hand show robo2 expression in different subsets 


















Figure 2.9. A schematic of the robo2 rescue construct showing the  HA-Robo2 cDNA 
and the inserting site for non-Janelia GAL4 fragments that are located upstream of the 







Figure 2.10. (SEG01)::robo2. A. Stage 16 embryo stained with anti-HRP 
antibody(magenta), and anti-HA antibody(green) showing no expression of robo2 
in the lateral pathway at this stage of embryogenesis. B. Stage 13 shows a little 
(arrow) or no expression for the robo2 at this stage in the midline glia. Lower 









Figure.2.11. robo2 expression patterns driven by SEG02 and SEG03. A. 
(SEG02)::robo2 shows robo2 expression in a subset of the longitudinal pathway 
(A, arrow) and some neurons outside of the nerve cord (A, arrowhead) stained 
with anti-HA antibody. The nerve cord is stained with anti-HRP 
antibody(magenta), B. (SEG03)::robo2 shows robo2 expression in a subset of 
the lateral pathway (B, arrow) using anti-HA antibody(green), and anti-HRP- 
antibody(magenta) to stain Robo2 and the nerve cord, respectively. Lower 




Compare exogenous HA-Robo2 expression with the full robo2 expression (endogenous) and 
compare that with the Janelia GAL4 lines for each enhancer region 
 To investigate whether the putative enhancers would drive robo2 expression as strong as 
the native enhancer (not well understood yet), GMR28F02 and GMR28G05 fragments, gave 
strong expression in subsets of the robo2’s longitudinal pathway, were chosen for this 
comparison. Since we do not have a good Robo2 antibody, and even if we had one, it would not 
work with this experiment since the rescue transgene is also expressing Robo2. To overcome 
such obstacles, the CRISPR-Cas9 gene-editing tool has been used to generate a line where 
Robo2 was labeled with Myc tag. Flies that have Myc-Robo2 were crossed to the ones that have 
GMR28F02::HA-Robo2 and GMR28G05::HA-Robo2 separately (Appendix 4.4). Embryos were 
collected from the progeny of this cross were stained with anti-HA and anti-Myc antibodies. The 
results showed that some neurons are labeled with HA and Myc antibodies which indicated that 
both HA-Robo2 and Myc- Robo2 were expressed. Noticeably, HA-Robo2 and Myc- robo2 
expressions were found in subsets and the entire lateral pathways, respectively (Figure 2.12). To 
further investigate whether these two fragments (GMR28F02 and GMR28G05) can rescue the 
robo2 full expression in the lateral pathway, a recombinant line was made by crossing 
GMR28G05 and GMR28F02 transgenes separately to a CRISPR allele robo2 myc- robo2  line and 
their progeny {((GMR28G05):: robo2/ robo2 myc- robo2 , and (GMR28F02):: robo2/ robo2 myc- 
robo2 )} were crossed with each other. To make sure that both HA- and Myc- Robo2 were existed 
in the same fly, PCR reactions with specific primers were conducted. Positive embryos were 
collected and stained with anti-HA and anti-Myc. The results showed that HA still labels some of 
the Myc axons but not all of them. These findings suggested that the presence of one copy of 







Figure 2.12. Compare the endogenous robo2 expression with the exogenous HA-tagged 
robo2. A. Stage 16 embryo of (GMR28G05):: robo2 / robo2 Myc-Robo2 shows anti-Myc 
antibody labeling all the neurons that normally express robo2, and anti-HA antibody 
represents the exogenous robo2 driven by GMR28G05 fragment, labeling a subset of Myc 
(A, arrow show the region where both Myc and HA are labeled in the same embryo. ( A, 
arrowhead shows only Myc axons) B. Stage 16 embryo of (GMR28F02):: robo2 / robo2 
Myc-Robo2 shows anti-Myc antibody labeling the neurons that normally express endogenous 
Robo2, and anti-HA antibody labeling the exogenous Robo2 driven by GMR28F02 
fragment showing a subset of Myc labeled (B, arrows). C. Stage 16 embryo of genotype [ 
[(GMR28G05):: robo2], [ robo2 Myc-Robo2]/ [ (GMR28F02):: robo2], [ robo2 Myc-Robo2] 
shows the endogenous and exogenous robo2 expression resulted by a single copy of each 




     Then we asked whether the robo2 expression driven by the rescue constructs have identical or 
different patterns than the ones which led by the original Janelia GAL4 lines. The analysis of 17 
transgenic lines generated by Janelia GAL4, where GAL4 was expressed under the control of the 
robo2 DNA fragments sequence revealed that some of these fragments drove the expression in 
the longitudinal pathway and some of them showed the expression in the midline glial cells. 
(GMR28F02):: robo2, (GMR28G05):: robo2, (GMR28C04):: robo2, and (GMR28D10):: robo2 
of the rescue construct showed distinct expression patterns in different subsets of the longitudinal 
pathway at stage 16 of the embryogenesis and this is consistent with what Janelia GAL4 lines 
showed (Figure 2.13). On the other hand, while Janelia GAL4 lines GMR28E07 and GMR28B05 
showed expression in the midline glia at the stage16 of the embryogenesis, rescue constructs 
transgenes of the same fragments did not show the same expression at that stage. However, stage 



































Figure 2.13. (Cont.) Comparison of robo2 expression driven by the DNA fragments 
in the original Janelia GAL4 and the rescue construct transgens.1-4. robo2 expression 
driven by GMR28F02, GMR28G05, GMR28C04, and GMR28D10 fragments 
respectively in the Janelia GAL4 (A) and rescue construct (B). The lateral pathway is 
stained with anti-GFP antibody in A and anti- HA-antibody in B, and the nerve cord is 
stained with anti-HRP (blue in A) and (purple in B). Lower images represent the GFP 
and HA channels only. 
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Figure 2.14. (Cont.) Compare robo2 expression driven by GMR28E07 fragment in the 
original Janelia GAL4 and the rescue construct transgenes. A. Stage 16 embryo 
represents robo2 expression driven by GMR28E07 fragment in the midline glia of 
Janelia GAL4 line stained with anti-GFP (green) and the nerve cord is stained with anti-
HRP (blue). (B) Stage 16 embryo shows very little or no expression of robo2 driven by 
GMR28E07 fragment of the rescue construct transgene in this stage of embryogenesis. 
C. Stage 13 embryo represents robo2 expression driven by GMR28E07 fragment in the 
midline glia of rescue construct transgene stained with anti-HA antibody(arrowhead) 
and a subset of the longitudinal pathway (arrow). The nerve cord is stained with anti-
HRP (purple). Right image in A represents the GFP channel only and the right images 





































Figure 2.15. (Cont.) Comparison of robo2 expression driven by GMR28B05 fragment 
in the original Janelia GAL4 and the rescue construct transgenes. A. Stage 16 embryo 
represents robo2 expression driven by GMR28B05 fragment in the midline glia of 
Janelia GAL4 line stained with anti-GFP (green, arrowhead) and the nerve cord is 
stained with anti-HRP (blue).  (B) Stage 16 embryo shows very little or no expression of 
robo2 driven by GMR28B05 fragment in the rescue construct transgene in this stage of 
embryogenesis. C. Stage 13 embryo represents robo2 expression driven by GMR28B05 
fragment in the midline glia of rescue construct transgene stained with anti-HA antibody 
(green, arrowhead) and the nerve cord is stained with anti-HRP (purple). Right image in 





Combinatorial enhancers and robo2 full expression 
GMR28G05 and GMR28F02 transgenic lines show strong expression of the robo2 in 
subsets of the longitudinal lateral axons. The previous experiment described early in this chapter 
shows involving one copy of each fragment on each allele is not enough to drive the full 
expression of the robo2 in the longitudinal pathway. Therefore, we asked whether combining the 
two fragments (GMR28G05 and GMR28F02) as one big fragment would recover the full 
expression of the robo2. Gibson assembly approach was used to combine GMR28G05 and 
GMR28F02 fragments and introduce them to the HA-Robo2 reporter transgene. This reporter 
was introduced to Drosophila to generate a new transgenic line. Homozygous embryos of the 
progeny of this line were collected and stained with anti-HRP and anti HA antibodies. The 
results revealed that the number of cell bodies is doubled when the two fragments (GMR28G05 
and GMR28F02) were combined and integrated on the same chromosome in tandem compared 
to the few cell bodies that were labeled in the (GMR28G05):: robo2 and (GMR28F02):: robo2 
separately (Figure 2.16, C, arrowheads). However, the expression of the robo2 in the 



























Figure 2.16. Combinatorial expression of robo2 enhancers (GMR28G05+GMR28F02). A 
and B show robo2 expression which was led by GMR28G05 and GMR28F02 separately. 
Anti-HRP antibody labels Drosophila nerve cord and anti-HA antibody labels subsets of 
the robo2 in the longitudinal pathway (arrows) and some few neurons around the nerve 
cord (arrowheads). C. shows the tandem of (GMR28G05+GMR28F02) fragments on the 
same chromosome of the same embryo. Although the number of the labeled neurons with 
anti HA- antibody was increased, the longitudinal pathway still shows the robo2 




The rescue of axon guidance decision of robo2 mutant background 
This study shows that some of the DNA sequences surrounding the robo2 promoter are 
potential enhancers that can regulate robo2 expression in specific patterns. We hypothesized that 
these DNA regions that drove the expression of the robo2 in the longitudinal pathway should be 
able to rescue the lateral pathway defects in the robo2 mutant background. The same hypothesis 
can be applied to ensure that the fragments driving robo2 expression in the ipsilateral neurons 
can rescue the midline ectopic crossing defects caused by the loss of the Robo2. To test this 
hypothesis, the HA-Robo2 transgenes (GMR28G05):: robo2 and (GMR28F02)::rboo2 were 
introduced to robo2 null mutant background (Appendix 4), where small deletions occurred in 
the robo2 coding region due to imprecise excision of a p-element transposon upstream of the 
robo2 signal sequence. These deletions were designed to behave like genetic null alleles 
(Simpson, Bland et al.,  2000). Midline ectopic crossing and the lateral pathway defects were 
quantified comparing to the wild-type and robo2 mutant embryos. Data show that GMR28F02 
enhancer does not rescue the robo2 expression neither in the midline ectopic crossing nor in the 
longitudinal pathway. In other words, the expression driven by GMR28F02 was not sufficient to 
recover the defect that occurred in the midline glia and the lateral pathway in stage 16 in robo2 
mutant embryos. Statistical analysis shows the differences between the robo2 mutant carries the 
robo2 (GMR28F02):: robo2 transgene and robo2 mutant in both rescuing the midline ectopic 
crossing and the lateral pathway were not statistically significant (p= 0.2223) and (p=0.075), 
respectively (Figure 2.17, C, and bottom bar graphs).  robo2123/robo2135 embryos showed 22.1% 
instances of the lateral pathway formation defects, while robo2123, [GMR28F02-robo2]/robo2135, 
[GMR28F02-robo2] embryos, which are expected to show rescue of Robo2’s lateral positioning 
role, showed 18.6% instances of the lateral pathway defects indicating that the instances of the 
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lateral positioning defects in robo2123, [GMR28F02-robo2]/robo2135, [GMR28F02-robo2] showed 
a non-significant statistical difference from the 22.1% defects of hetero-allelic robo2 mutants, in 
other words, the presence of the GMR28F02- robo2 transgenic modification was not sufficient to 
rescue Robo2’s lateral positioning role. (Table 2.1). Also, robo2123/robo2135 embryos showed 
17.1% instances of midline ectopic crossing, and the instances of midline crossing rescue in 
robo2123, [GMR28F02-robo2]/robo2135, [GMR28F02-robo2] showed 22.9% which was 
statistically not different from the 17.1% defects of hetero-allelic robo2 mutants, indicating that 
the presence of the GMR28F02- robo2 transgenic modification was not sufficient to rescue 
Robo2’s midline ectopic crossing role occurred by hetero-allelic robo2 mutants. 
 GMR28G05 on the other hand showed a rescuing for the midline ectopic crossing 
(P=0.0004). However, its expression was not enough to rescue the lateral pathway defects since 
there were no significant differences in the lateral longitudinal pathway between robo2 transgene 
carrying GMR28G05 (robo2 (GMR28G05):: robo2) and robo2 mutant background (p=0.0813) 
(Figure 2.18, C, and bottom bar graphs). Homozygous-allelic robo2 mutants of genotype 
robo2135/robo2135 showed instances of the midline ectopic crossing of 40.06% while robo2135, 
[GMR28G05-robo2]/robo2135, [GMR28G05-robo2] showed instances of 7.14% in the midline 
ectopic crossing, indicating that the instances of ectopic midline crossing in robo2135, 
[GMR28G05-robo2]/robo2135, [GMR28G05-robo2] showed a significant statistical difference 
from the 40.06% defects of homo-allelic robo2 mutants (Table 2.2). Instances of the lateral 
pathway defect in Homozygous-allelic robo2 mutants were 20.7%while robo2135, [GMR28G05-
robo2]/robo2135, [GMR28G05-robo2] showed 6.42% instances in the lateral pathway, which was 
not significantly different from the 20.7% of homo-allelic robo2 mutants (Table 2.2). 
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In addition to the single fragment rescue experiment, I performed crosses between the 
line carrying the combination of GMR28G05 and GMR28F02 ((GMR28G05+GMR28F02):: 
robo2) and robo2 mutant background line to obtain embryos of homozygous-allelic genotype for 
the robo2 mutations robo2135, [GMR28G05+GMR28F02-robo2]/ robo2135, 
[GMR28G05+GMR28F02-robo2]. These embryos were stained, imaged, and scored for defects 
in the formation of the lateral axon pathways and ectopic axons crossing the midline (Figure 
2.18, D). Homozygous-allelic robo2 mutants of genotype robo2135/robo2135 were also scored in 
the same way. robo2135/robo2135 embryos showed 20.7% instances of the lateral pathway 
formation defects, while robo2135, [GMR28G05+GMR28F02-robo2]/robo2135, 
[GMR28G05+GMR28F02-robo2] embryos, which are expected to show rescue of Robo2’s 
lateral positioning role, showed 4.45% instances of the lateral pathway defects indicating that the 
instances of the lateral positioning defects in robo2135, [GMR28G05+GMR28F02-
robo2]/robo2135, [GMR28G05+GMR28F02-robo2] showed a significant statistical difference 
from the 20.7% defects of homozygous-allelic robo2 mutants, demonstrating that the presence of 
the combinatorial transgenic modification was sufficient to rescue Robo2’s lateral positioning 
role (Table 2.2). Also, robo2135/robo2135 embryos showed 40.06% instances of midline ectopic 
crossing, and the instances of midline crossing rescue in robo2135, [GMR28G05+GMR28F02-
robo2]/robo2135, [GMR28G05+GMR28F02- robo2] showed 10.72% which was statistically 
different from the 40.06% defects of homozygous-allelic robo2 mutants, indicating that the 
presence of the combinatorial transgenic modification was sufficient to rescue Robo2’s midline 
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Figure 2.17. (Cont.) robo2 rescue using single fragment (GMR28F02). (A-C) Stage 16 
embryos stained with anti-HRP (magenta) and anti-FasII (green) antibodies. Lower 
images show FasII channel alone for the same embryos. FasII-positive axons in robo2 
null mutants cross the midline inappropriately in some segments (B, arrow), and show 
defects in the lateral pathway (B, arrow with asterisk). This phenotype is not rescued by 
the robo2 (GMR28F02):: robo2 transgene having GMR28F02 fragment that drives robo2 
expression in the lateral pathway (C, arrow with asterisk ) and midline (C, arrow). Bar 
graphs in the bottom indicate instances of ectopic midline crossing (left) and the lateral 
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Figure 2.18. (Cont.) robo2 rescue using GMR28G05 and combinatorial (tandem) of 
GMR28G05+GMR28F02 putative enhancer regions. (A-C) Stage 16 embryos stained 
with anti-HRP (magenta) and anti-FasII (green) antibodies to label the nerve cord and 
axon pathways, respectively. Lower images show FasII channel alone for the same 
embryos. Medial FasII axons cross the midline ectopically in homozygous robo2 null 
mutants (B, arrow), and the lateral axon pathways do not form appropriately (B, arrow 
with asterisk). This phenotype is rescued in the midline by the robo2(GMR28G05)::robo2 
transgene having GMR28G05 fragment (C, asterisk). However, this fragment did not 
rescue the lateral defect occurred by robo2 null mutant (C, arrow, and asterisk). On the 
other hand, combinatorial of two fragments GMR28G05+GMR28F02 shows fully rescue 
of robo2 expression in the midline and the lateral pathway(D). Bar graph on the left 
bottom indicates instances of restoring ectopic midline crossing in 
robo2(GMR28G05)::robo2 and robo2(GMR28G05+GMR28F02)::robo2 and on the right 
bottom indicates instances of rescuing the lateral pathway defects in the 
robo2(GMR28G05)::robo2 and robo2(GMR28G05+GMR28F02)::robo2. Error bars 
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Generate and characterize an equivalent set of robo2 transgenes expressing the axonal 
marker TauMyc instead of the HA-Robo2 
 Robo2 is expressed normally in a subset of longitudinal axons. To unravel the robo2 
candidate enhancers underlying the expression in these axons without relying on robo2 
expression, I generated an equivalent set of the robo2 transgenes that express the axonal marker 
TauMyc. This transgene consists of Drosophila robo2 promoter followed by TauMyc cDNA. 
The embryos of this transgene were collected and stained by anti-HRP and anti-Myc antibodies. 
However, the expression was too weak to be studied (Figure 2.20, A). robo2 promoter was 
replaced by hsp70 promoter since the first one did not show a good expression. The GMR28F02 
fragment was cloned into the TauMyc construct (Figure 2.19), and TauMyc expression was 
examined in embryos carrying this transgene. Results show that GMR28F02 fragment in 
hsp70(GMR28F02)::TauMyc drove strong TauMyc expression in a subset of the lateral neurons, 
it also labeled the cell bodies and axons including commissural axon segments from which 
Robo2 protein is expressed (Figure 2.20, B). 
The previous studies show that robo2 misexpression prevents longitudinal axons to form 
correctly (Simpson, Bland et al.,  2000). Robo2 in recent experiments has shown responsibility 
for regulating axon guidance in both ways, cell-autonomously and cell non-autonomously. In 
robo2 mutants, FASII positive lateral axons fail to form appropriately. It is unknown whether 
these FASII axons express Robo2, so they show defects in their expression when robo2 is 
missing. Or axons that express Robo2 normally show the same defects that FASII axons show, 
and whether these axons always colocalize with FASII positive axons. We utilized the generated 
transgenic line that expresses TauMyc in a subset of longitudinal axons that express robo2 
normally (hsp70(GMR28F02)::TauMyc) to test that. This transgene is introduced into robo2 null 
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mutant background and TauMyc axon positions were quantified by measuring their distances 
from the midline in five hemi segments of each embryo in both wild-type and robo2 null mutant. 
FASII axons positions were also quantified in the same way. Results show that TauMyc label 
axons express a significant guidance defects in robo2 mutants (****p<0.0001). These axons 
show shifting to positions closer to the midline. The average distance of these axons from the 
midline is 9.66 µm in the robo2 mutants while it is 13.11 µm in the wild-type. While the HRP 
axons are 15.23 µm in distance from the midline and TauMyc axons usually make a position of 
13.11 µm in the wild-type, the mutants with the whole scaffold are down to 9.04 µm for the HRP 
and the TauMyc axons right now are 9.66 µm. FASII axons show multiple breaks and shifting 
from and between zones. They show a significant defect in robo2 mutant (****p<0.0001). FASII 
average distance from the midline is 11.97 µm in the wild-type. However, their distance from the 
midline in robo2 mutant is down to 7.41 µm. 
I have generated another transgenic line that expresses the axonal marker TauMyc in a 
subset of longitudinal neurons that express Robo2 normally by using GMR28G05 
(hsp70(GMR28G05TauMyc). Embryos from this transgenic line were collected, stained with 
anti-HRP, anti-FASII, and anti-Myc antibodies. Interestingly, TauMyc axons that express Robo2 














Figure 2.19. A schematic of TauMyc construct showing TauMyc cDNA with hsp70 promoter 




















































Figure 2.20. (Cont.) Non-autonomous role of Robo2 in the formation of the lateral 
pathway. A. GMR28F02::TauMyc embryos at stage 16 shows TauMyc, an axon marker 
expresses Robo2 normally in the lateral pathway stained with anti-HRP (blue), anti-FASII 
(red), and anti-Myc (green). B. hsp70(GMR28F02)::TauMyc embryo where Robo2 
promoter was replaced by HSP70 to show TauMyc axons clearly. C. 
hsp70(GMR28F02)::TauMyc in robo2 mutant background (Robo2135) showing the lateral 
FASII pathways do not form correctly (lower channel, arrows), and they do not colocalize 
with TauMyc axons (arrows in C, and second lower channel of C, and third lower channel 
of C). TauMyc axons do not show the same defects that FASII show in robo2 mutant 
background (hsp70(GMR28F02)::TauMyc /Robo2135. D.  hsp70(GMR28G05)::TauMyc 
where Robo2 promoter was replaced by HSP70 second lower channels show isolated 
FASII channels from the same embryos. Third layer images show isolated TauMyc 
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T a u M y c
Figure 2.21. Bar Graphs showing the defect that FASII and TauMyc axons display in 
hsp70(GMR28F02)::TauMyc in robo2 mutant background. The distance between FASII 
and TauMyc axons and midline was measured for five locations per embryo. Each variant 
was compared in +, hsp70(GMR28F02)::TauMyc embryos and mutants by a Student’s-
test. We detect a statistically significant decrease in a distance from the FASII and 
TauMyc axons to the midline in embryos expressing hsp70(GMR28F02)::TauMyc in 
robo2 mutant background (robo2135) compared to wild type embryos expressing 





 Robo2 is a member of conserved protein family that responds to Slit ligand and plays a 
role in several aspects of axon guidance (Evans et al.,  2015). The question remains as to the 
ways by which Robo2 acts in making such different functions. robo2 expression has previously 
been shown to be transient through embryonic developmental stages (Rajagopalan, Vivancos et 
al.,  2000). While Robo2 is broadly expressed in the CNS during the early stages of development, 
its expression becomes more limited to axons in the lateral one-third of the longitudinal pathway 
in later stages. This project hypothesizes that different regulatory regions surrounding the robo2 
gene direct robo2 expression in a specific special and temporal pattern during embryonic 
development, and this expression is orchestrated by gene control mechanisms through regulating 
regions that control robo2 expression in specific cell types or specific developmental stages. 
With one or multiple enhancers controlling one aspect of robo2’s expression. The research in 
this chapter focuses on the robo2 fragments role in driving a specific robo2 expression in the 
lateral pathway and midline glial cells. The fragments tested in this chapter have been confirmed 
to be able to drive a specific robo2 expression in the lateral axons and glial cells indicating that 
these putative enhancers exist on these fragments. For instance, GMR28F02, GMR28G05, 
GMR28C04, and GMR28D10 drove robo2 expression in the lateral pathway. Two more 
overlapping fragments (SEG02 and SEG03) generated in our lab (not included in the original 
Janelia GAL4) that are located upstream of the robo2 gene have shown expression in the lateral 
pathway as well. Moreover, two other fragments (GMR28E07 and GMR28B05) showed 
expression in the midline glia. Even though there is no overlapping between GMR28E07 and 
GMR28B05 fragments, the expression patterns that they show is identical in both Janelia GAL4 
lines and the rescue construct transgenes at almost all stages. They both show an expression in 
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the midline glial cells. However, these two fragments are separated from each other by 
GMR28A10 fragment. Interestingly this fragment (GMR28A10) does not show any expression 
in Janelia GAL4 lines even if a part of GMR 28A10 sequence overlaps with GMR28B05. Figure 
2.4. I suggest that using CRISPR cas-9 based gene-editing to delete the region shared between 
GMR28A10 and GMR28B05 from GMR28B05 fragment and then combine the remaining 
fragment of GMR28B05 with GMR28E07 fragment would be sufficient to drive robo2 full 
expression in the midline glia.  
 Putting the rescue constructs in the robo2 mutant background drove the expression of 
robo2 in subsets of the lateral pathway and midline to play a role in these two positions. 
However, these constructs represented by (GMR28G05):: robo2, and (GMR28F02):: robo2, 
separately failed to rescue the whole function of Robo2 in the lateral pathway formation. 
Interestingly, (GMR28G05):: robo2 construct that expected to rescue robo2 expression in the 
longitudinal pathway displayed restoring of the essential Robo2 function to prevent midline 
ectopic crossing. To explain that, we need to look closer to the original Janelia GAL4 lines, 
GMR28G05-GFP line shows some of the cells are expressed in the midline, which makes it 
possible for (GMR28G05):: robo2 to rescue the ectopic midline crossing. The question still 
arises as why transgenic constructs that led the expression in specific cell subsets were not able 
to completely rescue the robo2 expression in that position? If we go back to the initial screening 
of Janelia GAL4 lines we can notice that multiple lines besides tested ones showed GFP 
expression in the lateral pathway and midline glia. In other words, not only the tested lines 
expressed Robo2 in different cell types and different stages, but also some other lines showed 
GFP expression, but that expression was hard to define accurately, which suggests that multiple 
fragments may be required to regulate a single aspect of robo2 expression. Also, some of Janelia 
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GAL4 lines such as GMR28E07-GFP and GMR28B05-GFP that showed expression at stage 16, 
the same expression was missing in the rescue transgenes at the same stage. One possible 
explanation for that is because of the difference in the expression duration between Janelia 
GAL4 lines and the rescue construct transgenes. The GFP expression pattern can be seen in both 
early and late stages of Janelia GAL4 lines while the expression pattern was restricted to earlier 
stages of the embryogenesis in the rescue transgenes. Robo2 cytosolic mRNA appears for a short 
time before being translated to a protein. However, GFP lasts longer than the mRNA and that is 
why it shows the robo2 expression at later 16 stages while the actual expression was in the stage 
13 of the embryogenesis. 
The rescue of the axon guidance decision of robo2 mutant background by the 
combinatorial of robo2 enhancers 
 Since single fragment transgenes did not show a full rescue for the longitudinal pathway 
of robo2 expression, I hypothesized that combinatorial of two fragments that have expression 
patterns in the longitudinal pathway would rescue the robo2 expression in the lateral pathway. 
GMR28G05 and GMR28F02 fragments were combined in tandem in one construct and injected 
into wild-type fly by Best gene, then a fly stock balancer made and crossed to the mutant 
background. homozygous-allelic genotype embryos with respect to the Robo2 mutations 
robo2135, [GMR28G05+GMR28F02-robo2]/ robo2135, [GMR28G05+GMR28F02-robo2] were 
collected, stained, imaged, and scored for defects in the formation of the lateral axon pathways 
and for ectopic axon crossing of the midline. Homozygous-allelic robo2 mutants of genotype 
robo2135/robo2135 were also scored in the same way. The homozygous-allelic genotype robo2135, 
[GMR28G05+GMR28F02-robo2]/ robo2135, [GMR28G05+GMR28F02-robo2] was able to 
rescue the robo2 expression not only in the lateral pathway formation but also in the midline 
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repulsion. The instances of the lateral positioning defects in robo2135, [GMR28G05+GMR28F02-
robo2]/robo2135, [GMR28G05+GMR28F02-robo2] showed significant statistical difference from 
the defects of homozygous-allelic robo2 mutants in both lateral and midline ectopic crossing. 
Together, these results confirm that multiple enhancer regions are required to restore the full 
robo2 expression.  
TauMyc marker transgene confirm cell non-autonomous role of Robo2 
Robo2 receptor regulates the lateral positions of the axons in the VNC of Drosophila 
CNS by responding to Slit ligand. Drosophila wild-type embryos show three FASII positive on 
both sides of the midline. The previous studies show removal of robo2 causes fusing the lateral 
FASII pathway with the intermediate pathway and directs the lateral axons medially (Ströhl et 
al.,  2017). Another study shows that robo2 misexpression prevents the formation of the 
longitudinal pathway appropriately (Simpson, Bland et al.,  2000). Moreover, ectopic expression 
of robo2 lead the medial axons to be extended laterally. (Simpson, Bland et al.,  2000; Spitzweck 
et al.,  2010) show that replacing robo2 by robo1 causes the lateral pathway fails to form 
correctly. However, HA-positive axons that express Robo1 instead of Robo2 still able to be 
expressed laterally. We need to know if axons expressing Robo2 normally show any defects in 
robo2 mutant background and whether this defect looks like the one that FASII axons show. We 
also want to know the autonomy express of Robo2 by normally expressing axons. The previous 
studies showed that Robo2 can act cell-autonomously and non-autonomously to regulate the 
lateral axons. We show here that TauMyc axons that normally express Robo2 in the lateral axons 
act as cell non-autonomously in robo2 mutant. However, the defects they show is different than 
the one that FASII show. The question remains as to whether TauMyc axons colocalize with 
FASII axons. The answer is no. Although they both show significant defects by being shifted 
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from the midline in robo2 mutants, they still do not show the same defects and navigation in 
their expression. Together, these data show that FASII and TauMyc axons are not the same. 
Not only GMR28F02 was cloned in the TauMyc construct, but also GMR28G05 was 
cloned in the same construct. Unlike hsp70(GMR28F02)::TauMyc, hsp70(GMR28G05): 
:TauMyc did not show any expression. We do not know if this missing of expression has been 
occurred due to the replacing of the endogenous promoter by hsp70 or it happened in the original 
transgene when we replaced the robo2 construct by TauMyc. To answer this question, I suggest 
that looking at the original expression of the (GMR28G05::TauMyc) transgene before replacing 
the promoter would be more helpful, by generating a new transgene that has GMR28G05 














I have presented here transcriptional regulation of the robo2 gene in Drosophila CNS. 
Screening of 17 Janelia GAL4 transgenic lines by using the GAL4-UAS system yielded six 
promising fragments (GMR28F02, GMR28G05, GMR28E07, GMR28B05, GMR28C04 and 
GMR28D10). Four of these fragments showed strong expressions, two in the longitudinal 
pathway (GMR28F02 and GMR28G05), and the other two showed expression in the midline glia 
(GMR28E07 and GMR28B05). Rescue construct for these six fragments in addition to three 
fragments generated in our lab (SEG01, SEG02, and SEGO3) showed robo2 expression in 
subsets of the longitudinal pathway driven by 6 fragments (GMR28G05, and GMR28F02, 
GMR28C04, GMR28D10, SEG02, and SEG03). GMR28G05, and GMR28F02 showed the 
strongest expression, and two of the remainder rescue construct transgenes showed robo2 
expression in the midline glia driven by GMR28E07, and GMR28B05 with similar expression 
levels for both. While putting transgene of a single fragment (putative enhancer) in robo2 mutant 
background did not rescue robo2 expression, a combinatorial of two fragments showed a rescue 



























      Regulatory regions are non-coding DNA sequences that regulate genes transcriptions through 
the transcription factors. One of these regulatory regions is an enhancer. Enhancers increase the 
transcription of genes and they can be located upstream, downstream, within the introns, or in a 
long distance from the gene they regulate. Multiple enhancers might be required to act in 
coordination to regulate a gene transcription. Results from the previous chapter suggest that 
Robo2 can be led by multiple enhancers. GMR28G05 and GMR28F02 fragments, which led the 
strongest expression of robo2 in the longitudinal pathway, are potentially the multiple enhancers 
for robo2. To examine this finding, the CRISPR-Cas9 system was used to delete both fragments 
separately and together. Change in robo2 expression in the longitudinal pathway will give insight 
into the role of these fragments. Also, knowing which transcription factor(s) might bind to the 
above fragments would help us to unveil the role(s) of these fragments regarding to robo2 
transcription. Thus, bioinformatics tools and literature were utilized in the second part of this 
chapter. I found three promising transcription factor candidates (Hb9, Nkx6.1 and Lhx2) that 
potentially bind GMR28G05 and GMR28F02 with the following DNA consensus binding motifs 
(TAATTA), (TTAATTG), and (TAATTA), respectively. These findings may open new avenues 








     Understanding genetic variations and their association with causing diseases is important, 
especially for human health. While studies show that a mutation in the protein-coding gene 
regions can lead to most pathogenic alterations, mutations in the non-coding sequences can affect 
gene regulation and pathways involved in specific diseases such as cancer (M. B. Patel & Wang, 
2019). Intron sequences make up about 25% of the human genome, which is 4∼5 times the size 
of exons (Sakharkar et al.,  2004). Introns can play a protective role for the eukaryotic genome 
sequences by occupying 40% of the total length of the gene and eventually most of the random 
mutations will occur in the intron regions, keeping the protein sequences and functions safe. 
However, a mutation in the intronic regions can lead to tumorigenesis by affecting the splicing in 
direct manner and causing malignant transcript isoforms, making introns crucial for the cell 
health. Introns can impact protein variety by affecting alternative splicing and Drosophila Dscam 
gene represents an excellent example of increasing protein variety. It can produce more than 
38,000 isoforms that can be produced from alternative splicing (Pan et al.,  2008). Furthermore, 
introns have a potential effect in enhancing gene expression and researchers prefer including 
introns in designing constructs in order to guarantee a higher level of expression(Clark et al.,  
1993). Studies in mammals and yeasts confirm that genes with their introns show a higher level 
of expression than those without introns (Juneau et al.,  2006; Shabalina et al.,  2010). Although 
current genome-wide discovering revealed a wide number of functional genes in the DNA 
coding regions, the functional elements in the non-coding sequences of human genome are not 
fully uncovered. Due to the critical role of non-coding sequences of human genome in different 
aspects, such as being involved in the transcription factor binding, chromatin states, and 
modification resulted from epigenetics, more studies would be required (Li et al.,  2014). 
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     This chapter focuses on testing the effect of putative enhancers located on the first intron of 
the robo2 gene on its protein expression. The results from the previous chapter suggested that 
multiple enhancers are necessary for leading the robo2 expression in the longitudinal pathway 
and two fragments (GMR28G05 and GMR28F02) located in the first intron of the robo2 gene 
showed the strongest expression of robo2 in the lateral pathway. However, it is not known 
whether the robo2 expression will be affected by the absence of these two fragments. In this 
chapter, I used CRISPR-Cas9 to make deletions in a region of the robo2 first intron. I deleted 
GMR28G05 fragment (3.8 Kb) and GMR28F02 fragment (3.7Kb). Both GMR28G05 and 
GMR28F02 fragments and in between fragment, the total DNA length was 11.5Kb, were deleted 
as well and the robo2 gene expression will be monitored.  
CRISPR-Cas9 as a precise tool in genome editing 
     Clustered regularly interspaced short palindromic repeats (CRISPR-Cas9) is the most recent 
discovery in genome editing technology that enables researchers to precisely manipulate the 
DNA sequence of any genome. It was first discovered as a family of the DNA sequence belongs 
to bacteriophages that previously infected prokaryotes. Prokaryotes used these DNA sequences 
to detect and destroy any DNA identical to the bacteriophage during successive infections. For 
this reason, these sequences are considered a defense system that prokaryotes use against viral 
infection. (Barrangou, 2015). Cas 9 is an enzyme guided by the guide RNA (gRNA) sequence to 
recognize and cleave the DNA sequence that is complementary to the gRNA sequence. Since 
then CRISPR-Cas9 has been the cornerstone of gene-editing in different organisms. (Zhang et 
al.,  2014). It provides a vigorous multifunctional gene-editing tool, allowing researchers to 
accurately manipulate genome elements, and facilitating of targeting genes. This technique has 
been utilized in both molecular biology and disease treatment. It was successfully used to target 
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important genes in many organisms and cell lines. (https://www.neb.com/tools-and-
resources/feature-articles/crispr-cas9-and-targeted-genome-editing-a-new-era-in-molecular-
biology).  
     Unlike alternative genome editing technologies such as zinc-finger nuclease (ZFNs) and 
transcription activator-like effector nucleases (TALENs), which depend on the use of 
customizable DNA-binding protein nucleases, The CRISPR-Cas9 system has a discernible 
benefit over these technologies. Using RNA-based CRISPR provides simplicity and flexibility 
for genome editing. For this reason, CRISPR has revolutionized biomedical research, and 
become one of the most essential approaches for genome engineering (Kim et al.,  1996; Smith 
et al.,  1999; Bibikova et al.,  2001; Boch et al.,  2009; Moscou & Bogdanove, 2009; Christian et 
al.,  2010; Tianfang Ge et al.,  2016).  
     The Cas9 mediated genome editing system requires only three components:1. Cas9 that can 
be available as a gene, mRNA, or purified protein, 2. gRNA, which can be supplied as an RNA 
or transcribed from the DNA template in vivo. 3. DNA donor holding the target sequence which, 
in turn, involves a novel sequence to be inserted or indels. 
     In the CRISPR-Cas9 system, cas9 makes a DNA double-strand break (DSB) and the next step 
involves repairing the DSBs, which occurs by one of two major repair pathways (Figure 3.1): 1. 
The non-homologous end-joining (NHEJ) pathway, which considered an efficient but error-
prone pathway, and 2. The homology-directed repair (HDR) pathway, the less efficient but high-
fidelity. Unlike HDR, NHEJ does not require a DNA template with homology to the sequences 
flanking the DSB. NHEJ, therefore, generates insertions or deletions during DSB repair. The 
efficiency of NEHJ is higher than HDR and the repairing time is shorter (tens of minutes). NHEJ 
is useful if there is a requirement of making a null allele (Knockout) in the gene of interest. 
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HDR, on the other hand, requires a presence of the DNA template homology to the DSB location 
flanking sequence. As a result, repairing the broken DNA strands occurs in an error-free manner. 
While NHEJ is active throughout the cell cycle, HDR can be used by the cell only if the 
homology DNA is present in the nucleus in specific phases (most likely G2 and S phase) of the 
cell cycle. In addition to the cell cycle, the efficiency of HDR depends on the concentration of 
the DNA that exists during repairing time, the homology arm length of the donor DNA, and the 
efficiency of the endogenous repair systems. HDR is used to make an insertion (Knockin) in the 
gene of interest (Figure 3.1)(Lin et al.,  2014; Iliakis et al.,  2004; Hasty et al.,  1991; Wolf-
Dietrich Heyer, 2008; Pardo et al.,  2009). In this chapter, the CRISPR-Cas9 approach was used 
to create a deletion in robo2 regulatory regions including GMR28G05 and GMR28F02 
















Figure 3.1: CRISPR/cas9 Genome Editing Mechanism. The complex of Cas9 and gRNA 
binds with the DNA close to the PAM sequence. Cas9 generates a DNA double-strand 
break (DSB) 3-4 bp upstream of the PAM sequence, this DSB can be repaired via NHEJ, 
which might result in insertion or deletion or in a frameshift that causes gene knockout, or 
HDR, which can cause gene knockin if the DNA donor is provided with homology in the 





Transcription factors and gene expressions 
     Generally, the transcription of genes is controlled by different ways and one of them is the 
interaction of the transcription factors to specific DNA sequences. Sometimes these proteins are 
encoded by genes that are in a different place of the genome from the genes that they regulate; 
therefore, they are called trans-acting factors. When these proteins bind to their regulatory 
elements of the same DNA fragment that has the gene that they regulate, these regulatory 
elements are called cis-acting factors. The transcription of genes is mediated by the RNA 
polymerase enzyme that plays an important role in catalyzing the RNA synthesis and this RNA 
is complementary in sequence to the DNA template. There are three RNA-polymerases in 
eukaryotes: RNA polymerase I (Pol I),which is responsible for transcribing genes that encode the 
ribosomal RNA, RNA polymerase II ( Pol II or RNA PII), which transcribes genes into mRNA, 
and RNA polymerase III(Pol III) that transcribes genes that encode the tRNA and the small 
nuclear RNA (Kadonaga, 2004). 
     Pol II is a large protein with a molecular mass of 600 KDa consists of 10-12 subunits. This 
protein can transcribe RNA from DNA. Despite its capability to catalyze mRNA synthesis, Pol II 
cannot bind to the DNA and initiate the transcription by itself without the assembly of specific 
proteins called general transcription factors. There are six general transcription factors that are 
important for class II genes transcription. These factors are TFIIA, TFIIB, TFIID, TFIIE, TFIIF, 
and TFIIH. These transcription factors by assembling with the Pol II make the pre-initiation 
complex or the basal transcriptional machinery and the latter assembles with the promoter region 
of the DNA (Kadonaga, 2004; Hahn, 2005). 
DNA promoter consists of many regions that are incorporated in the transcription process. A 
TATA box region, which is essential for recognizing the RNA Pol II, an initiator ( Inr) box, 
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which consists of a stretch of nucleotides sequence in the DNA from where the transcription 
lunches, and the upstream controller elements region that binds to the RNA Pol II (Schramm & 
Hernandez, 2002). 
     RNA Pol II should interact with the DNA before the transcription initiates, and for this 
interaction to happen, general transcription factors should bind to TATA box and Inr. The first 
general transcription factor that binds to the DNA template is TFIID (Kadonaga, 2004; Nikolov 
& Burley, 1997). TFIID consists of a TATA-binding protein (TBP), a highly conserved protein 
that plays a vital role in all eukaryotic transcription. TBP has an antiparallel β-sheet that can sit 
on the minor groove of the DNA and make a conformational changing in the DNA double-
strand. TBP has also an α-helix domain, which is considered the recognition motif between the 
transcription factor and the DNA by binding to the DNA major groove. After binding to the 
DNA, TFIID starts to recruit TFIIB that can bind to TBP and GC- rich DNA sequence 
downstream of TATA motif at the same time. The TFIIB-TBP-DNA complex gives the order for 
the RNA Pol II to start the transcription and choose one of the two strands of the DNA to be the 
template. Binding the N- terminal domain “zinc ribbon “(a cystin-rich, zinc-binding region) of 
TFIIB to the RNA Pol II activates the recruitment of the RNA pol II and this, in turn, pulls the 
initiation complex to the RNA Pol II surface and the DNA, in this case, will easily reach to the 
active site. For the transcriptional initiation to start, it requires TFIIF that plays an active role in 
the formation of strong complex with the RNA Pol II, which recruits TFIIE, and TFIIE, in turn, 
helps to recruit TFIIH, the most complex structure amongst all other general transcription 
factors. The complex of the RNA Pol II, core promoter, and general transcription factors is called 
the pre-initiation complex (PIC). TFIIH has the ATPase/ helicase subunit, which hydrolyzes the 
ATP to melt the promoter (unwinding the DNA double-strands) by TFIIE assistance. TFIIF 
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captures the non-template DNA strand while the template strand goes to the RNA Pol II active 
site. (Hahn, 2005; (Kadonaga, 2004)  
Transcription factors and enhancers 
     Since basal transcriptional machinery of general transcription factors and the RNA Pol II are 
not sufficient for gene transcription, additional proteins are needed to facilitate this process, and 
these proteins are called transcription factors that are able to identify and bind to the gene 
enhancers. The DNA looping model proposes that the basal transcriptional machinery assembles 
with the gene promoter and the transcription factors bind to the gene enhancer. looping out the 
DNA intervening allows the transcription factors to physically interact with the basal 
transcriptional machinery and this interaction will energize gene transcription. The interactions 
between the amino acid side chains of transcription factors and the DNA bases of purine and 
pyrimidine determine the accuracy of transcription factor binding to the DNA through the non-
covalent hydrogen bonds between the amino acids and the DNA bases. The transcription factor 
peptide can bind to the major groove of the DNA (Rohs et al.,  2010). This interaction between 
the transcription factor and the DNA may happen electrostatically by the formation of the salt 
bridge with anionic phosphate groups (Luscombe, 2001). 
     Transcription factors are grouped in families based on sequence conservation and tertiary 
structure determined from X-ray crystallography and nuclear magnetic resonance spectroscopy. 
Members of each family have the same certain structural motifs for the DNA binding. These 
structures are zinc finger, basic zipper (Bzip), helix-turn-helix (HTH), basic helix-loop-
helix(bHLH), and β-sheet. These motifs are composed of a specific tertiary protein structure in 
which its α-helix component interacts with the DNA major groove. Transcription factors are 
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capable of recognizing a short sequence of about 12 base pairs in most cases (Boron & 





























        





Examples of specific transcription factors 
Factor Structural type Recognition sequence Binds as 
SP1 Zinc finger 5'-GGGCGG-3' Monomer 
AP-1 Basic zipper 5'-TGA(G/C) TCA-3' Dimer 
C/EBP Basic zipper 5'-ATTGCGCAAT-3' Dimer 
Heat shock factor Basic zipper 5'-XGAAX-3' Trimer 
ATF/CREB Basic zipper 5'-TGACGTCA-3' Dimer 
c-Myc Basic helix-loop-helix 5'-CACGTG-3' Dimer 
Oct-1 Helix-turn-helix 5'-ATGCAAAT-3' Monomer 
NF-1 Novel 5'-TTGGCXXXXXGCCAA-3' Dimer 
(G/C) = G or C 
X = A, T, G or C 
Table 3.1 Transcription factors and the DNA sequences they recognize 
 




Predicting transcription factors that bind specific sites 
     Characterizing of the transcription factor binding sites (TFBSs) on the genomic DNA has 
become a big challenge after the publication of the complete sequence of the human genome. To 
identify the complete set of functional elements in these sites, many approaches have been 
utilized including experimental and computational comparisons of associated genomes. 
Transcription factors and the DNA sites that they bind are the most critical elements in any 
genome. The transcriptional regulatory network resulted from the interaction between the TFs 
and the DNA provides a big insight into the potential functions of the genes that are regulated by 
these DNA binding sites. Multiple methodologies have been used to detect the DNA sites that 
TFs bind to, such as gel shift assay, and Southern blotting of the DNA and proteins. However, 
these approaches are not efficient in terms of the time that they consume and being unable to 
cover the whole genome. Therefore, another technique was used later which is called SELEX 
(Systematic Evolution of Ligands by Exponential Evolution) to find the high-affinity binding 
sequences which is modified then to the genomic SELEX that uses the genomic library for the 
selections. In recent times, CHIP-chip assay, the highest throughput technique, is broadly used to 
identify genomic TFBSs in vivo.  
     In silico, many computational methods have been used to predict the proteins that can bind to 
the DNA and a method called a position weight matrix (PWM), or a position-specific scoring 
matrix (PSSM) is the most common method used to represent the degenerate sequence preferring 
of the DNA binding protein. In this computational method, the elements of PWM represent the 
scores that reflect the frequency of observing of a certain nucleotide at a certain position of 
specific or putative TFBSs. Despite the high accuracy in identifying of TF binding in vitro, the in 
vivo binding of these TFs might not occur or might not represent a direct regulatory function that 
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the in vitro binding shows. However, this defect does not belong to the computational 
techniques, but it is related to some biological facts, such as chromatin structures and 


















Material and methods 
gRNA design 
      All the target sequences were identified using the National Center for Biotechnology 
Information (NCBI) website to direct cas9- mediated cleavage to target the GMR28G05 and 
GMR28F02 regions. CRISPR target finder website was used to design gRNAs with 100% off-
target cleavage (http://tools.flycrispr.molbio.wesc.edu/targetfinder). The gRNAs were cloned 
into PCFD4 plasmid (port et al,2014) (Appendix 5). The following primers (Appendix3, table 2), 
800 and 801 primers for GMR28G05, and 798 and 799 for GMR28F02, and 798 and 801 primers 
for GMR28G05+ GMR28F02, were annealed by PCR. The PCR products were inserted into 
BbSI- digested PCFD4 backbone using Gibson assembly Ultra Kit (Cat no.:GA1200-10). In the 
case of GMR28G05 gRNA an additional G nucleotide was added to the 5՛ end of the 
GMR28G05 gRNA target sequence to facilitate the transcription from the U6-1 promoter 
(Addgene plasmid no. 49411). The resulting plasmid was cloned into E-coli competent cells.    
Preparing the DNA for injection 
     A mixture of cas9 encoding the DNA plasmid (Appendix 5) and two gRNAs encoding 
plasmids for each deletion was used in a concentration of 500ng/µl for cas9 and 250ng/µl 
plasmids in a total volume of 20 µl. 2 µl of filtered food dye diluted 1:100 in distilled water was 
added to the 20 µl of the injection mixture. Needles used for the injection were made up of 
capillary tubes of 100 mm length, 1.0 mm outside diameter, 0.56 mm inside diameter 
borosilicate glass capillaries with filament (# 1 B100F-4 World precision Instruments Inc, 
Sarasota, FL). Capillaries were pulled by using P-100 Faming/ Brown Micropipette Puller 
(Sutter Instruments. Novato, A). A program with the following parameters was used to pull the 
needles: Heat 590, Pull 115, Velocity 15, Time 250, Pressure 600, and Ramp 590. Needles were 
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loaded with 1 µl of injection mix using an Eppendorf loader tip (Eppendorf), fitted into a needle 
holder attached to a syringe to facilitate injection, and controlled by a micromanipulator 
(Figure.3.2). The tips of the needles were opened with a micro-dissection scissor as needed. 
Embryos injection 
     Fly stocks were amplified in advance to get enough eggs for injection. Approximately 300 
mature flies of genotype roborobo2/robo2robo2 were transferred to an egg-lay cage with an apple 
juice plate incubated at 25˚C for at least one day prior to the injection day to get the flies 
accustomed. Embryos were collected on the apple juice plate each 20-30 min with the apple juice 
plate change each time the embryos were collected and yeast paste was spread in the center of 
the plate. The collected embryos were rinsed with water, and dechorionated for 60 s in 6% 
sodium hypochlorite, washed with tap water and lined up on a slide with a coverslip and covered 
with extra virgin organic olive oil. The slide with the embryos was moved to a Nikon TS 100 
inverted microscope equipped with a micromanipulator. Embryos were injected by moving the 
stage to insert the needle in the posterior end of the embryo (Figure 3.2.A-C). The pressure was 
applied to the syringe until the DNA moved into the embryos which is monitored through the 
blue food dye. Injected embryos were thoroughly washed with ethanol 95% to remove the olive 
oil, then the ethanol was washed off with distilled water. The excess water on the coverslip was 
drained by applying the coverslip’s edge onto a clean tissue. The coverslip was transferred into a 
food vial, pushed down into the food with the embryos anterior up until the embryos touched the 
food, so when the larvae hatch, they will crawl into the food. The marked food vials were placed 

























Figure 3.2. Drosophila embryo injection setup. A and B, (left, embryos), (right, injection 
needle). C. Drosophila embryos are injected by moving the stage to insert the needle in 
the posterior end of the embryo. 
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PCR analysis of the CRISPR-Cas9 deletions 
     After injected embryos have reached adulthood, the G0 flies were crossed 1:3 to Sco/CyOwg 
virgins. After 3 days of crossing, adults were removed and screened with PCR using primers 
811, 812 for GMR28G04, 813, 814 for GMR28F02, and 811,814 for GMR28G04+ GMR28F02 
(Appendix 3, Table 2). The progeny of positive PCR F1 will be collected to make a stock. 
In silico studies for the transcription factors of robo2 first intron putative enhancers 
     Depending on the predicted transcription factors taken from the literature, I used two 
bioinformatics websites JASPAR 2020 (http://jaspar.genereg.net/) and the footprint database 
(FootprintDB) website (http://floresta.eead.csic.es/footprintdb/index.php?search_entries) to 
investigate whether these candidate transcription factors can bind to robo2 putative enhancers  
(GMR28G04 and GMR28F02). The candidate transcription factors from literature were 
submitted through JASPAR 2020 website to provide the ID numbers of the nominated 
transcription factors. These ID numbers were utilized to find the predicted consensus regions by 
using the FootprintDB website and the DNA logo that represents the probability of the 
nucleotides in each DNA transcription factor binding site. These consensus regions were aligned 
with robo2 fragments sequences using Clustal Omega 






Results and Discussion 
     In this chapter CRISPR/Cas9 was utilized to delete GMR28G05 and GMR28F02 fragments 
separately or together by using non-homologous end-joining (NHEJ). gRNAs were designed and 
inserted into PCFD4 plasmid. The constructed plasmids were confirmed by PCR (Figure 3.3) 
and sequencing (Figure.3.5A-C), then cloned in E. coli competent cells. These plasmids were 
injected alongside with Cas9 expressing plasmid into flies that have CRISPR allele where the 
genomic robo2 was replaced by the HA-Robo2. Injected embryos were raised, crossed to 
Sco/CyOwg and offspring were collected for screening to identify the deletion in these 
fragments. A total of 666 embryos were injected with a mix of the GMR28G05 gRNA and the 
Cas9 plasmids, 216 embryos were injected with a mix of the GMR28F02 gRNA and the Cas9 
plasmids, and 226 embryos were injected with a mix of the GMR28G05+GMR28F02 gRNA and 
the Cas9 plasmids (Table.3.2). Of the injected embryos, 21 survived of GMR28G05, 7 survived 
of GMR28F02, and 4 survived of GMR28G05+ GMR28F02 to adulthood. After crossing to 
Sco/CyOwg, potential founders of each group (GMR28G05, GMR28F02, and 
GMR28G05+GMR28F02) produced offspring of 16, 5, 3, respectively. The injection survival 
rate was 3.15%, 3.24%, and 1.76% of injected embryos to adulthood for GMR28G05, 
GMR28F02, and GMR28G05+GMR28F02 respectively and fertility rate found for those adults 
was 76.1% for GMR28G05, 71.4% for GMR28F02, 75% for GMR28G05+GMR28F02 
(Table.3.2). 
     In general, the results of injection show that there is a low survival rate which, in turn, 
reduced the efficiency of the deletion. The rate of survival is comparable with another graduate 
student in our laboratory. Besides the low rate of survival of injected embryos, SARS-CoV-2 
(COVID-19) pandemic has negatively affected my research. The university closure during the 
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pandemic has stopped my research and I was not able to test most of the injected flies. In future 
studies, I suggest that additional trials with improved techniques such as electroporation for 



















Table.3.2. CRISPR Data for Drosophila embryo injection. 
Injection mix No. of injected 
embryos 
%(no.) adult G0 
survival 




GMR28G05 666 3.15(21) 76.1(16) - 
GMR28F02 216 3.24(7) 71.4 (5) - 
























































































Figure 3.3 gRNA and CAS9 vectors confirmation. A.2µl of miniprep DNA of gRNAs 
in PCFD4 vector (GMR28G05 gRNA in PCFD4 595bp, GMR28F02 gRNA in PCFD4 
595bp, and GMR28G05+GMR28F02 gRNA in PCFD4 600bp). B. 2µl of miniprep of 
pAct-cas9 vector 700bp.Plasmid sizes compared to 1Kb Plus DNA Ladder from 





















Figure 3.5A Schematic construction of GMR28G05 guide RNA in pCFD4.The pCFD4 
plasmid was used to deliver the 5’ and 3’ gRNAs. Oligo 800 was used for the fwd. prime 
and 801 for the rev primer. gRNAs are under the control of U6:1 and U6:3 promoters 











Figure 3.5B Schematic construction of GMR28F02 guide RNA in pCFD4.The pCFD4 
plasmid was used to deliver the 5’ and 3’ gRNAs. Primer 798 was used for the fwd. 
primer and 799 for the rev primer. gRNAs are under the control of U6:1 and U6:3 






















Figure 3.5C Schematic construction of GMR28G05+GMR28F02 guide RNA in 
pCFD4.The pCFD4 plasmid was used to deliver the 5’ and 3’ gRNAs. Oligo 798 was used 
for the fwd. primer and 801 for the rev primer. gRNAs are under the control of U6:1 and 




Transcription factor candidates that can potentially bind to robo2 putative enhancers 
(GMR28F02 and GMR28G05) 
1. Hb9 transcription factor (exex in Drosophila) 
     Hb9 transcription factor (exex), also known as Extra-extra, Q9VSC2_DROME, and 
RE39081p, in Drosophila embryos, can regulate axon guidance by acting upstream of robo2 and 
robo3. This transcription factor is necessary for robo2 expression in ventrally extending motor 
neurons. In Hb9 mutants, restoring Robo2 activity plays an important role in motor axon defect 
rescue. Hb9 can regulate Robo2 over its conserved repressor domain and acts in parallel with 
NKX6.1. Robo2 and Robo3 play a key role as Hb9 effectors to regulate the nervous system 
development and Hb9 can regulate the mediolateral positioning of axons through Robo2 and 
Robo3. A previous study accomplished on Hb9+ cells that express Robo2 in which robo2 
expression was scored, robo2 mRNA expression shows a decrease in Hb9+ mutant (Landgraf et 
al.,  1997; Santiago et al.,  2014). 
     To examine whether Hb9 could be a transcription factor that regulates robo2 expression by 
binding GMR28F02 and GMR28G05, I used a combination of two bioinformatics websites 
(JASPAR 2020, and FootprintDB, http://floresta.eead.csic.es/footprintdb/index.php) as described 
in the materials and methods section. I found that the specific binding motif of Hb9 (TAATTA) 
is found at two locations of GMR28F02 and three locations of GMR28G05 (Figure.3.6) 
     These results were expected because Robo2 has been detected as an effector of Hb9 in motor 
neurons. Also, both Robo2 and Hb9 mutants share the same defects in the lateral positioning. 
Together, these data propose that Hb9 might regulate the medial and the lateral positions of a 
subset of interneurons by affecting Robo2. Apterus axon in the wildtype embryos projects its 
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fascicle in the medial FasII pathway on both sides of the midline. robo2 overexpression in the 
Apterus neurons shifts their axons laterally (Evans & Bashaw, 2010; Rajagopalan et al.,  2000b; 
Simpson et al.,  2000a). Overexpression of Hb9 shows a similar phenotype by shifting apterus 
axons laterally. Importantly, overexpression of Hb9 in apterus neurons results in robo2 
upregulation significantly. In robo2 mutants (when both copies of robo2 were removed), 
overexpression of Hb9 led to full suppression in Hb9’s gain of function phenotype while Apterus 
axons still look like a wildtype (Santiago et al.,  2014), which means that ectopic expression of 















F02 nt 250-255:  
CCCATTTTTCCTCAGCACTTAATTACGCTCATTTGGCATATATGCTCTTCATTTG 
F02 nt 2770-2775:  
TATGTACATTTTCTTACATTAATTATAAAGTAACTATTTTTTTTACAATACCAGT 
G05 nt 1716-1721: 
GACATTCCATTTTCGCTATAATTAATAAACACACGGCAAAACAATTTATCAGTT 
G05 nt 2456-2461: 
CTGCCAAAACGAACAACATAATTACCGTTAAGAATTGCGAGTTGCAACATCAGC 
G05 nt 3527-3532: 
TGCGGAGCCAAAGTTGGCTAATTAGCTATGCAAACTATGAGATACACAACACAA 
Figure 3.6. Predicted DNA binding motif sequence of Hb9 in GMR28F02 and GMR28G05. A. 
Logo of the DNA binding motif sequence of Hb9 shows the probability of nucleotides in the 
sequence (adapted from  http://floresta.eead.csic.es/footprintdb/index.php). B. locations and 
numbers of the DNA binding motif sequence of Hb9 in GMR28F02 and GMR28G05. (F02 and 










     NKX6.1, Also known as NKX6A and HGTX, is one of the homeodomains transcription 
factors that belong to the NK family whose genes products are involved in specifying of the cells 
fate and differentiation in specific tissues. It is expressed in the ventral part of the neural tube of 
the mouse and chick embryos (Jørgensen et al.,  1999). It has an important role in the spinal cord 
and motor neurons specification in addition to its role in axon projecting and muscle targeting in 
motor neurons (Sander et al.,  2000; Thaler et al.,  1999; Garcia & Jessell, 2008; Arber et al.,  
1999; Vallstedt et al.,  2001). In Drosophila, NKx6.1 is expressed in embryonic motor neurons 
that extend to the lateral or ventral body wall muscles and they are necessary for motor axons 
that project ventrally (Broihier & Skeath, 2002; Broihier et al.,  2004; Odden et al.,  2002). In 
addition to the motor neurons, NKx6.1 has shown expression in a subset of interneurons. 
Drosophila NKx6.1 can act as an activator or repressor; however, none of these activities were 
tested in vivo (Syu et al.,  2009).   
     To test the binding ability of NKX6.1 on GMR28F02 and GMR28G05 fragments, I followed 
the same procedure as in the previous transcription factor (Hb9). I found two locations of the 
consensus sequence (TTAATTA) of NKX6.1 in GMR28F02 while one consensus sequence 










GMR28F02 nt 250-256: 
CCCATTTTTCCTCAGCACTTAATTACGCTCATTTGGCATATATGCTCTTCATTTGT 
GMR28F02 nt 2770-2776: 
TATGTACATTTTCTTACATTAATTATAAAGTAACTATTTTTTTTACAATACCAGT 
GMR28G05 nt 2562-2568: 
CAGAACGTTTTGGGCTCCTTAATTGCCATTGGTAGACTCCATTTGGCATGGCCGC 
Figure 3.7. Predicted DNA binding motif sequence of NKX6.1 in GMR28F02 and GMR28G05. 
A. Logo of the DNA binding motif sequence of NKX6.1 shows the probability of nucleotides in 
the sequence (adapted from  http://floresta.eead.csic.es/footprintdb/index.php). B. locations and 
numbers of the DNA binding motif sequence of NKX6.1 in GMR28F02 and GMR28G05. (F02 










      Homeodomain proteins compared to other transcription factors are indistinctive in their 
specificity to bind the DNA. These proteins recognize the consensus sequence ATTA, the DNA 
sequence that can be recognized by many different homeodomain proteins in vitro (Gehring et 
al.,  1994; Mannervik, 1999). Since many gene promoters contain the same core motif “TAAT” 
in their sequences, determining the downstream target becomes more complicated. Therefore, 
knowing the flanking sequence of this core motif is of utmost important goal to reduce the 
binding affinity. A study accomplished by (Jørgensen et al.,  2007) shows that using in vitro 
binding site selection reveals identifying the DNA sequence of NKx6.1 binding site of 
TTAATTG/A . 
     Another study conducted by (Mirmira et al.,  2000) showed an approach to identify the 
optimal DNA binding by NKX6.1 homeodomain. The coding sequence of NKX6.1 was fused to 
6 tandem histidine residues (His6) at N- terminus and expressed in E-coli, then the expressed 
NKX6.1 protein was purified and used to select for the DNA binding from a library of 55 bp 
nucleotides that have a central region of 15 random nucleotides. After isolation of protein and its 
bound DNA, the selected DNA sequence was amplified by PCR and used for several selection 
rounds. Multiple PCR product sequences were aligned to give the consensus sequence of 
TTAATTAC. This study comes in agreement with the previous study done by Jorgensen et al 
with an addition of one nucleotide (C) at the 3՛ of TTAATTA (TTAATTAC) sequence motif, 






3. Lhx2 transcription factor 
     Lhx2is a transcription factor that regulates numerous developmental aspects in different 
embryonic stages including proliferation control of progenitor, specification of the cell fate of 
post-mitotic progeny, cell differentiation, and axon pathfinding (Chou & Tole, 2019). Lhx2 is 
also known as ap; GJ14977; apterous; GJ14977-PA; GJ14977-PB. According to (Subramanian 
et al.,  2011), Lhx2 plays a central role in regulating the neuron-glia cell fate decision in the 
hippocampus. (Marcos-Mondéjar et al.,  2012) showed that robo2 mRNA expression is repressed 
by the LIM-HD transcription factor Lhx2 in postmitotic thalamic neurons. Lhx2 overexpression 
in rostral (rTh ) and intermediate (iTh ) thalamic neurons results in an improper invasion of 
Thalamocortical axons (TCAs) in improper regions of the hypothalamus which, in turn, 
decreasing the number of axons that reach the cortex in a process similar to that of the absence of 
Slit/robo signaling (Bagri et al.,  2002; López-Bendito et al.,  2007). 
     In silico studies that I conducted using bioinformatics websites (explained in materials and 
methods), I found that the DNA motif (TAATTA) of Lhx2 (Fig3.8. A) can bind two locations of 












GMR28F02 nt 250-257: 
CCCATTTTTCCTCAGCACTTAATTACGCTCATTTGGCATATATGCTCTTCATTTGT 
GMR28F02 nt 2770-2776: 
TATGTACATTTTCTTACATTAATTATAAAGTAACTATTTTTTTTACAATACCAGT 
G05 nt 1716-1721: 
GACATTCCATTTTCGCTATAATTAATAAACACACGGCAAAACAATTTATCAGTT 
G05 nt 2456-2461: 
CTGCCAAAACGAACAACATAATTACCGTTAAGAATTGCGAGTTGCAACATCAGC 
G05 nt 3527-3532: 
TGCGGAGCCAAAGTTGGCTAATTAGCTATGCAAACTATGAGATACACAACACAA 
Figure 3.8. Predicted DNA binding motif sequence of Lhx2 in GMR28F02 and GMR28G05. A. 
Logo of the DNA binding motif sequence of Lhx2 shows the probability of nucleotides in the 
sequence (adapted from  http://floresta.eead.csic.es/footprintdb/index.php). B. locations and 
numbers of the DNA binding motif sequence of Lhx2 in GMR28F02 and GMR28G05. (F02 and 












     It was expected to find several hits of the DNA binding motif of Lhx2 in GMR28F02 and 
GMR28G05 sequences. It has been involved in directly regulating Robo2 function in 
commissural neurons of the developing spinal cord of mice by binding to specific regulatory 
sequences of robo2. The phylogenetic footprinting analysis of regions 20kb upstream and 70kb 
downstream of robo2 transcription initiation site shows four putative robo2 regulatory regions 
that can bind Lhx2 with evolutionarly conserved regions, and CHIP assay shows that Lhx2 binds 
significantly to the robo2-region 3. These results indicate that Lhx2 acts as a transcriptional 
regulator for robo2 expression in thalamic neurons of mice when it binds to the regulatory region 
in the robo2 gene in vivo. Putative Lhx2 DNA binding region shows 6bp consensus sequences in 
robo2. CHIP assays experiments show a specific enhancer region (TAATTA) in robo2 is the 
target sequence that Lhx2 binds in the spinal cord of E12-5 embryonic stage of thalamic tissue in 













     To sum up, this chapter presents the importance of introns in gene expression and how 
deleting single or multiple regulatory regions might affect robo2 expression. The CRISPR/Cas9 
system was utilized to make a deletion of GMR28G05 and GMR28F02 from robo2 first intron 
separately or together. The deletion efficiency was severely reduced due to the low injection 
survival rate. Besides, the SARS-CoV-2 (COVID-19) pandemic has stopped my research and as 
a result many of the injected flies have not been tested for the deletion. With additional trials and 
using more effective techniques such as electroporation, it will be possible to get these fragments 
deleted and see the effect of this deletion on robo2 expression. The second part of this chapter 
focuses on predicting the transcription factors that can potentially bind to robo2 putative 
enhancers. Both bioinformatics tools and literature were utilized to find these predicted 
transcription factors. Hb9 (exex in Drosophila) with its consensus binding motif to the putative 
enhancers (TAATTA), Nkx6.1 with (TTAATTG) sequence, and Lhx2 with (TAATTA) binding 
motif were transcription factor candidates that can potentially bind to robo2 putative enhancers 





























      Robo2 is a transmembrane protein that regulates three distinct roles in directing axon guidance 
in Drosophila central nervous system (CNS). These different roles of Robo2 depend in part on its 
distinct functional domains and on the dynamic transcription in different subsets of cells through 
embryogenesis in another part. Robo2 structural and functional domains in Drosophila were 
studied comprehensively in the previous years. However, little is known about the transcriptional 
regulation of robo2. This study focuses on testing multiple regions in and around the robo2 gene 
that could potentially be enhancers for robo2 in Drosophila. To find the robo2 putative enhancers, 
seventeen transgenic lines created by Janelia Research Center were utilized. Each line has one 
fragment of robo2 predicted enhancer inserted upstream of the yeast transcriptional activator 
GAL4. The seventeen lines were crossed to another transgenic line containing a GAL4 responsive 
GFP (UAS-TauMycGFP) to create a protein reporter system. Six promising enhancer candidates 
(GMR28F02, GMR28G05, GMR28C04, GMR28D10, GMR28B05, GMR28E07) from the 
seventeen transgenic lines were found. Among these fragments, GMR28F02 and GMR28G05 
showed strong expression in the longitudinal pathway and two other fragments (GMR28E07 and 
GMR28B05) showed strong expression in the midline glia. To ensure the above fragments enhance 
the robo2 gene expression, I have created rescue construct transgenic lines for these six fragments 
in addition to three fragments created in our lab (SEG01, SEG02, and SEG03). All nine fragments 
were introduced into the HA-Robo2 reporter transgene. robo2 showed an expression in all these 
fragments except SEG01, and GMR28F02 and GMR28G05 were the strongest expression. To 
further investigate whether GMR28F02, GMR28G05 fragments can rescue robo2 expression, I 
introduced these fragments separately or together into robo2 mutant background. The combination 
of two fragments showed better rescue of robo2 expression in the mutant background compared 
112 
 
to a single fragment. These results suggest that multiple enhancer regions might be required to 
restore robo2 full expression.  
     I also generated and characterized an equivalent set of robo2 transgenic lines that express the 
axonal marker TauMyc instead of robo2. This transgene consists of GMR28F02 or GMR28G05, 
and hsp70 promoter followed by TauMyc cDNA. The results showed that unlike GMR28G05, 
GMR28F02 drove strong expression in subsets of the lateral neurons, cell bodies, and commissural 
axons. Moreover, GMR28F02::TauMyc was introduced into robo2 null mutant background. The 
results showed that TauMyc axons that normally express Robo2 in the lateral axons act as cell 
non-autonomously in robo2 mutant and they are different from FasII positive axons that are found 
on both sides of the midline of Drosophila nerve cord.  
      The first and the biggest intron of robo2 was hypothesized to play an important role in robo2 
expression and our results strongly agreed with that and indicated that GMR28F02 and 
GMR28G05 changed robo2 expression. The CRISPR/Cas9 system was utilized to delete these 
fragments separately or together. After CRISPR/Cas9 and gRNAs vectors were successfully 
constructed and confirmed by the PCR and the DNA sequencing, they were injected into 
Drosophila embryos. Most of these embryos were not examined for deletion because of the SARS-
CoV-2 (COVID-19) pandemic, which stopped my research. Further trials and using more efficient 
techniques such as electroporation could facilitate deleting GMR28F02 and GMR28G05 
fragments and study the effect of their deletion on robo2 expression.   
     Additionally, knowing which transcription factor(s) might bind to GMR28G05 and GMR28F02 
fragments would help us to reveal the role(s) of these fragments regarding to robo2 transcription. 
Thus, bioinformatics tools and literature were utilized. Three promising transcription factor 
candidates were found (Hb9, Nkx6.1 and Lhx2) that potentially bind GMR28F02 and GMR28G05 
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with the following DNA consensus binding motifs (TAATTA), (TTAATTG), and (TAATTA), 
respectively. These findings may open new pathways to understand the transcriptional regulation 
of robo2 regarding its enhancers. In the future, using Chromatin Immunoprecipitation (CHIP) 
assay with specific antibodies for those predicted transcription factor proteins could provide strong 
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Appendix 2: List of generated stocks 










HSP70[GMR28F02:: TauMyc]/ CyO,wg 
HSP70[GMR28G05:: TauMyc]/ CyO,wg 
[GMR28F02:: robo2],[ robo2Myc-robo2]/ CyO,wg 
[GMR28G05:: robo2],[ robo2Myc-robo2]/ CyO,wg 


























Appendix 3. Primers used in this research 
Table 1: Primers used to generate rescue construct transgenes. 
 






















































































































































































Appendix 4: Fly crosses to make stocks 
 
Appendix 4-1. The rescue of axon guidance decision of robo2 mutant background: 
The GMR28G05::robo2 transgenic line is generated by BestGene Inc (Chino Hills, CA). 
Injected (G0) individuals were crossed as adults to Sco/CyOwg to make a balanced stock. 
The balanced stock female flies were crossed to robo2 mutant background 
males(robo2135/CyOwg). F1 virgin females were then crossed to Sco/CyOwg males. F2 
single 10 red-eyed males (positive to the transgene) were crossed individually to 3-5 
virgin Sco/CyOwg females. After three days, the F2 males were removed from the 
crosses and tested by PCR. F3 progeny from positive F2 crosses were used to generate 












Appendix 4-2. The rescue of axon guidance decision of robo2 mutant background: 
The GMR28F02::robo2 is generated by BestGene Inc. (Chino Hills, CA). Injected (G0) 
individuals were crossed as adults to Sco/CyOwg to make a balanced stock. The balanced 
stock female flies were crossed to robo2 mutant background(robo2135/CyOwg). F1 virgin 
females were then crossed to Sco/CyOwg males. F2 single 10 red-eyed males (positive to 
the transgene) were crossed individually to 3-5 virgin Sco/CyOwg females. After three 
days, the F2 males were removed from the crosses and tested by PCR. F3 progeny from 


















Appendix 4-3. The rescue of axon guidance decision of robo2 mutant background: 
The GMR28F02::robo2 is generated by BestGene Inc. (Chino Hills, CA). Injected (G0) 
individuals were crossed as adults to Sco/CyOwg to make a balanced stock. The balanced 
stock female flies were crossed to robo2 mutant background(robo2123/CyOwg). F1 virgin 
females were then crossed to Sco/CyOwg males. F2 single 10 red-eyed males (positive to 
the transgene) were crossed individually to 3-5 virgin Sco/CyOwg females. After three 
days, the F2 males were removed from the crosses and tested by PCR. F3 progeny from 




















Appendix 4-4: Driving robo2 expression by putative enhancers vs. robo2 native 
enhancer. To check whether robo2 putative enhancers could drive robo2 expression as 
strong as the native robo2 enhancer, (GMR28G05) or (GMR28F02)::HA- Robo2 
transgenic lines were crossed with flies that were labeled with myc tag that represent the 





Appendix 5: Plasmid construction maps. Each map is annotated with the vector name, 
inserts (Janelia and non-Janelia fragments), the size of the vector, the promoter, epitope 











































































































































                                         









                                               
                                                  Adapted from https://www.addgene.org. 
 
 
